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ABSTRACT OF DISSERTATION

PROBING THE FUNCTIONAL RELEVANCE OF REACTIVE HIPPOCAMPAL
NEUROGENESIS IN A MODEL OF AN ALCOHOL USE DISORDER
Alcoholism, or alcohol use disorders (AUDs), represent a major public
health concern both locally and globally. Critically, excessive alcohol consumption
results in neurodegeneration in brain regions such as the hippocampus which is
known for its role in learning and memory. Recovery of hippocampal volume loss
has been observed after prolonged abstinence, but the mechanisms underlying
this process are not well understood. Adult neurogenesis is thought to contribute
to this recovery since after alcohol exposure a reactive increase in adult
neurogenesis is observed. This reactive neurogenesis (the process by which brain
insult results in a compensatory increase in neurogenesis) may represent a
beneficial endogenous mechanism of brain recovery. However, the role of alcoholinduced reactive neurogenesis in hippocampal recovery is not known. We
hypothesize that this reactive neurogenesis promotes the functional recovery of
the hippocampus following a 4-day binge model of an AUD. To that end, the
experimental studies herein were developed to decrease reactive proliferation to
study its impact on hippocampal function (learning and memory). The first set of
experiments attempted to decrease reactive proliferation by administering alcohol
during the period of increased proliferation. Although these experiments were
unsuccessful, they triggered an informative investigation into the timing of alcoholinduced reactive neurogenesis. The second set of experiments established an indepth time course and revealed that increased proliferation occurred 5-7 days after
binge alcohol exposure. With the new time course of proliferation in mind, the third
set of experiments used an anti-proliferative drug that successfully decreased
alcohol-induced reactive proliferation/neurogenesis but revealed no differences
between groups in a hippocampal-dependent task. The fourth set of experiments
revealed that granule cells born during reactive neurogenesis were capable of
activation. In conclusion, the finding that reactive neurogenesis resulted in neurons
capable of activation indicated that reactive neurogenesis may be involved in
promoting the recovery of hippocampal function. These studies furthered our
understanding of the role of alcohol-induced reactive neurogenesis in recovery

from AUDs. Furthermore, these studies provided valuable insight into modulation
of the NPC pool as a potential therapeutic target for the treatment of AUDs.
KEYWORDS: Alcohol use disorder, neurogenesis, reactive proliferation, reactive
neurogenesis, binge ethanol exposure.
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CHAPTER 1: INTRODUCTION
1.1 INTRODUCTION
This chapter contains excerpts from a previously published manuscript
(Geil et al., 2014) which have been reproduced with permission from Elsevier
and in accordance with guidelines provided by the University of Kentucky
Graduate School.
Adult neurogenesis is now widely accepted as an important contributor to
hippocampal integrity and function but also dysfunction when adult neurogenesis
is affected in neuropsychiatric diseases such as alcohol use disorders (AUDs).
Excessive alcohol consumption, the defining characteristic of AUDs, results in a
variety of cognitive and behavioral impairments related in part to the structural
and functional integrity of the hippocampus. Recent preclinical work has shown
that adult neurogenesis may be one route by which alcohol produces
hippocampal neuropathology. Alcohol is a pharmacologically promiscuous drug
capable of interfering with adult neurogenesis through multiple mechanisms. This
introduction discusses AUDs and the primary mechanisms underlying alcohol
induced changes in adult hippocampal neurogenesis including alcohol's effects
on neurotransmitters and hippocampal integrity.
1.2 ALCOHOL AND ALCOHOL USE DISORDERS
1.2.1 Alcohol use disorders
According to the fifth edition of the Diagnostic and Statistical Manual of
Mental Disorders (DSM-5) AUDs, more commonly called alcoholism, are
classified based on disease severity (mild, moderate, severe); which corresponds
1

to the number of diagnostic criteria an individual possesses (American
Psychiatric Association et al., 2013). A sampling of the 11 criteria include 1)
drinking more or for longer than intended, 2) unsuccessfully trying to reduce or
stop drinking, or 3) continuing to drink despite negative consequences (American
Psychiatric Association et al., 2013). Individuals are considered to have an AUD
if they meet a minimum of 2 criteria and 6+ criteria is indicative of a severe AUD.
AUDs represent major social and economic problems as well. Nearly
13.9% of the US population met the diagnostic criteria (in the last 12 months) for
an AUD (Grant et al., 2015). Additionally, the economic burden was estimated to
be $223.5 billion dollars annually (Bouchery et al., 2011). Further, excessive
alcohol consumption (including binge drinking) is the third leading cause of
preventable death in the United States (Mokdad et al., 2004). Alcohol is
responsible for approximately 88,000 deaths per year (Centers for Disease
Control and Prevention, 2006). More specifically, excessive alcohol consumption
was responsible for 1 in 10 deaths of working aged individuals in the US (Stahre
et al., 2014).
Although there are many theories about the development of AUDs, all
involve the fact that repeated bouts of excessive alcohol intake change the brain
in a way that drives a loss of control over consumption (Koob and Le Moal,
1997). This loss of control may be driven by hijacked learning processes,
impairments in behavioral control, and/or impaired decision making (Crews,
1999; Noel et al., 2013). All of these processes involve, at least partially, the
contribution of an intact hippocampus, and a wide variety of studies have shown

2

that excessive alcohol intake impacts the structure and function of hippocampal
circuitry.
1.2.2 Alcohol
Alcohol (ethanol) is a small, highly lipid soluble and pharmacologically
promiscuous drug capable of penetrating virtually every organ system including
the brain. Alcohol, more specifically ethanol, may have stimulant-like effects at
small concentrations but, unsurprisingly for those who have imbibed, it is in fact a
CNS depressant. Alcohol can have variable effects on individuals based on their
body size, gender, and race. Individuals of Asian descent are more prone to
facial flushing. Females are generally smaller than males and have less body
water, this results in less fluid for alcohol to be diluted in and therefore, women
become intoxicated with lower doses of alcohol. As such, charts used to
determine blood ethanol concentration (BEC) are based on weight and sex.
Alcohol consumption decreases blood flow to the cerebellum which could
account for deficits in hand-eye coordination and delays in reaction time which
makes driving very dangerous (Volkow et al., 1988). Excessive alcohol
consumption can also affect memory storage and retrieval; in extreme cases it is
called a blackout and can be categorized as a partial (greyout) or complete
blackout (McKim, 2007). During a partial blackout (greyout) individuals remember
bits and pieces of events that occurred while they were intoxicated and can be
reminded of things and will remember them. On the other hand, if an individual
had a complete blackout, the memories were never put into long-term storage,
which results in total memory loss (White, 2003). Individuals are conscious and
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appear to have intact recall of past events but long-term memories were not
created. This is likely caused by alcohol’s effect on the hippocampus, a brain
region needed to form long-term memories (McKim, 2007; White, 2003).
Excessive alcohol consumption has widespread deleterious effects on
many organ systems, but central nervous system injury is a critical consequence
as 50 to 75% of alcohol-dependent adults show permanent cognitive impairment
(Eckardt and Martin, 1986). These impairments are thought to be due to both
structural and functional changes resulting from excessive alcohol consumption
(Crews, 1999; Sullivan and Pfefferbaum, 2005). Alcohol appears to target some
brain regions more than others with a critical cluster of alcohol-induced
impairments in behavioral control, learning, memory, mood, and decision-making
attributed, at least in part, to the integrity of the hippocampus (Mechtcheriakov et
al., 2007). Because ethanol is so pharmacologically promiscuous, there are
many reported and potential mechanisms of alcohol-induced effects on the
hippocampus. The focus here is on the emerging role of adult hippocampal
neurogenesis in alcoholic neuropathology and the various potential mechanisms
involved in alcohol's effects on neural progenitor cells (NPCs).
1.2.3 Alcohol and neurodegeneration
Excessive alcohol consumption results in neurodegeneration in several
brain regions. Alcoholism in humans results in volume loss in cerebral cortex and
subcortical brain regions, reducing the number of both neurons (grey) and glial
cells (white matter tracts; reviewed in Crews and Nixon, 2009). These cortical
and subcortical regions include the limbic system, which is important for
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emotional processing, essential brain communication, and memory, among other
things (Oscar-Berman and Marinković, 2007). Interestingly, alcohol does not
uniformly affect the brain; the prefrontal cortex, hippocampus, cerebellum, and
white matter tracts and glial cells are the most affected (Alfonso-Loeches and
Guerri, 2011; Sullivan and Pfefferbaum, 2005). Human studies show decreased
brain size in postmortem and in vivo imaging studies (Oscar-Berman and
Marinković, 2007). Brain weight and volume loss in chronic alcoholics is primarily
due to white matter loss in the frontal lobe; however, several human and animals
studies have also shown neuronal cell loss (Chanraud et al., 2007; Pfefferbaum
et al., 1997; Sullivan and Pfefferbaum, 2005; Walker et al., 1980).
Glutamate’s upregulation during alcohol withdrawal results in glutamate
excitotoxicity (Chandler et al., 1993a, 1993b, Prendergast et al., 2000, 2004). In
vitro studies suggested that excitotoxicity may contribute to neurodegeneration
following alcohol exposure (Chandler et al., 1993a, 1993b). However, NMDA
glutamate receptor antagonists have not been successful in reducing
neurodegeneration caused by excessive alcohol exposure (Collins et al., 1998;
Corso et al., 1998; Crews et al., 2004a; Hamelink et al., 2005). Additionally, silver
stain (which is used to identify cell death) is observed during intoxication as early
as day two in a four-day binge model of an AUD (Collins et al., 1996; Obernier et
al., 2002a). In this four-day binge model of an AUD, peak cell death occurs on
the fourth and final day of the binge exposure (Crews and Nixon, 2009). As such,
it is unlikely that the mechanism of alcohol-induced neurodegeneration (in vivo) is
glutamate excitotoxicity. An alternative mechanism of alcohol-induced
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neurodegeneration is oxidative stress resulting from pro-inflammatory cell
signaling pathways (Crews and Nixon, 2009). cAMP responsive element-binding
protein (CREB) is a transcription factor that’s involved in neuroprotection against
oxidative stress (Lee et al., 2009) and during alcohol intoxication there is a
reduction in DNA binding of CREB (Crews and Nixon, 2009; Zou and Crews,
2005). Thus, oxidative stress and CREB-related signaling cascades represent a
potential mechanism of alcohol-induced neurodegeneration (because cell death
occurs primarily during intoxication and intoxication is linked to decreased action
of CREB and its downstream targets).
1.2.4 Alcohol and the hippocampus
Excessive alcohol consumption results in extensive deficits in
neuropsychological functions, many of which involve the hippocampus
(Chanraud et al., 2007; Ozsoy et al., 2013; Parsons, 1993). As has been
reviewed extensively elsewhere (Belujon and Grace, 2011; Eichenbaum, 2001;
Gilbert and Kesner, 2006; Johnson et al., 2007), the hippocampus is especially
critical for aspects of learning and memory and as such is implicated in the
acquisition, consolidation, and expression of memories associated with drug use
(Hyman et al., 2006; Nixon et al., 2011). Many now suggest a role for the
hippocampus in relapse and drug seeking as well (Belujon and Grace, 2011;
Vorel et al., 2001). This expanded role has emerged from data indicating the
hippocampus’s broad role in cognitive functions, specifically through its
interconnections with frontal cortices and reward systems. For example,
glutamatergic efferents projecting from the hippocampus and terminating in the
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prefrontal cortex (PFC) have been implicated in the proper processing of
executive functions, working memory, and contextual information (Godsil et al.,
2013). Therefore, disruptions in the structural integrity of the hippocampus may
be an underlying substrate for impairments in these functions. Certainly, longlasting deficits in executive function and working memory are observed following
excessive alcohol consumption (O’Daly et al., 2012; Stavro et al., 2013;
Stephens and Duka, 2008) and it is hypothesized that compromised hippocampal
integrity in alcoholics may contribute to these impairments. In support of this
hypothesis, a correlation between deficits in executive function and hippocampal
gray matter volume have been reported (Chanraud et al., 2007). Although
correlation does not imply causation, new evidence is mounting to support that
hippocampal integrity may influence a more broad range of cognitive functions
than classically considered. With new and improved technology, more consistent
reports of hippocampal pathology have emerged in the last several years
(Beresford et al., 2006; Ozsoy et al., 2013) including grey matter loss
(Mechtcheriakov et al., 2007). Debate is evident in the human literature over
whether the hippocampus is impacted by excessive alcohol; whether the left,
right, or both hippocampi are affected, whether degeneration is due to effects in
white or gray matter, and/or the magnitude of this effect (Agartz et al., 1999;
Laakso et al., 2000; Sullivan et al., 1995). Agartz et al. (1999) found the left
hippocampus to be larger than the right in men and women, but saw no
hippocampal volume difference between alcoholics and healthy subjects.
Although Agartz et al. (1999) did account for age and sex in their study, the more
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recent study by Beresford et al. (2006) used more stringent inclusion criteria
(excluding individuals with mental health issues like polysubstance abuse,
schizophrenia, depression, and post-traumatic stress disorder) and an MRI
capable of generating twice the magnetic field (Agartz et al., 1999; Beresford et
al., 2006). Beresford et al. (2006) revealed a decrease in hippocampal volume in
alcoholics compared to controls. The strict inclusion criteria and improved MRI
resolution provided by new instruments are likely responsible for the divergent
results from these studies. This study indicated that accounting for polysubstance
drug abuse, and mental health with appropriate controls is likely important for
accurately detecting differences in hippocampal volume. However, age should
also be considered since alcohol is particularly toxic to the hippocampus of the
adolescent brain (Ozsoy et al., 2013). Alcoholics that begin drinking during
adolescence show greater hippocampal volume deficits than those that began
drinking as adults (Ozsoy et al., 2013). However, greater anterior volume loss
was reported in the hippocampi of older alcoholics (Sullivan et al., 1995).
Regardless, the additive effect that alcohol damage has on the brain may be
responsible for some age-related differences and for that reason a measure of
lifetime alcohol consumption may be a better variable to control for than age of
disease onset. Earlier studies did not always properly account for confounding
variables such as sex differences, polysubstance drug use, mental health, and
age differences. Importantly, when these variables are accounted for and groups
are appropriately separated, as they are in more recent studies, the picture
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becomes clearer and the debate declines in favor of new evidence which
specifically shows hippocampal volume reductions in alcoholics.
Current imaging studies lack sufficient resolution to identify specific subregions of the hippocampus or cellular populations. Therefore, post-mortem
studies in humans and experimental evidence in animal models have been
necessary to offer insight into dentate gyrus specific effects and/or alcoholinduced neuronal loss. One study observed significant reductions in neuron
number in all hippocampal subfields, including the dentate gyrus, in alcoholics
less than 45 years old (Bengochea and Gonzalo, 1990). However, a more
rigorous stereological estimation failed to observe neuronal loss in any
hippocampal subfield, though these subjects were older, averaging 55 years of
age (Harding et al., 1997). Although Harding et al. (1997) associated
hippocampal volume deficits in alcoholic cases with white matter loss, others
have proposed that astroglial loss underlies hippocampal neurodegeneration
(Korbo, 1999). Nevertheless, animal models of chronic alcohol exposure have
shown consistently that alcohol is toxic to hippocampal neurons, including the
dentate gyrus granule cells (Cadete-Leite et al., 1988; Lukoyanov et al., 2000;
Walker et al., 1980). Furthermore, animal models allow researchers to examine
the effect of dose, duration and/or pattern of exposure which led to the discovery
that subtle evidence of damage in the hippocampus is apparent after as little as
24-48 hours of high dose, binge-like ethanol exposure (Hayes et al., 2013;
Obernier et al., 2002b). In the 4-day binge model of alcohol dependence,
neurons are lost throughout the corticolimbic pathway with degenerating cells
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particularly evident in the entorhinal cortex and ventral dentate gyrus (Collins et
al., 1996; Crews et al., 2000; Kelso et al., 2011; Obernier et al., 2002a, 2002b).
Importantly, these binge models mimic the high blood ethanol concentrations
(BECs) experienced by binge drinking alcoholics, which is estimated to be 60%
or more of the alcoholic population (Robin et al., 1998; Zeigler et al., 2005).
Additionally, alcoholics who drink in a binge pattern are much more likely to have
neurodegeneration (Hunt, 1993).
1.2.5 Recovery in abstinence
Human studies have shown that some portion of alcohol-induced
neurodegeneration and impairments in cognitive function can recover with
abstinence from alcohol (Bartels et al., 2007; Carlen et al., 1978; Gazdzinski et
al., 2005; Mann et al., 1999; Pfefferbaum et al., 1995). Research has shown that
hippocampal function returns to normal in alcoholics after two years of
abstinence for about half of the study participants (Bartels et al., 2007). Another
study noted that after four years of sobriety there were significant improvements
in overall memory and short-term memory (Rosenbloom et al., 2004). In addition,
hippocampal volumes increase and neuronal markers normalize one month into
abstinence (Gazdzinski et al., 2008). For the hippocampus, a host of plastic
changes were originally thought to underlie this recovery in rats, such as,
dendritic expansion (Cadete-Leite et al., 1988, 1989a, 1989b) and spine density
recovery (King, 1988); however, alcohol withdrawal may compromise some of
these effects (Durand et al., 1989). Although it has long been hypothesized that
this plasticity underlies recovery in hippocampal volume and/or function observed
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in animals (Lukoyanov et al., 2000) and humans (Bartels et al., 2007), the
contribution of these mechanisms seems insufficient to overcome the
hippocampal volume loss (16% decrease in total hippocampal volume) observed
in alcoholics compared to controls (Beresford et al., 2006). These theories,
however, did not take into consideration the newly accepted phenomena of adult
neurogenesis in the dentate gyrus (Armstrong and Barker, 2001; Nixon, 2006).
1.3 ADULT NEUROGENESIS – A CRITICAL COMPONENT OF HIPPOCAMPAL
INTEGRITY
Adult neurogenesis, the process by which new neurons are created in the
postnatal brain, occurs constitutively in two brain regions, the subventricular zone
(SVZ) of the walls of the lateral ventricles and the subgranular zone (SGZ) of the
hippocampal dentate gyrus (Altman and Das, 1965; Doetsch et al., 1999). Newly
generated SVZ neurons migrate via the rostral migratory stream to the olfactory
bulb which is primarily responsible for olfactory sensation. However, recent
discoveries about the lack of newborn neurons in the adult human olfactory bulb
(Bergmann et al., 2012) suggest that adult neurogenesis may only occur in the
hippocampus of adult humans. Altman and Das's (1965) pivotal discovery of
adult neurogenesis was not widely accepted until the late-1990s (Eriksson et al.,
1998; Gross, 2000; Kaplan and Hinds, 1977; Palmer et al., 1997). Since then
there has been a large increase in published work on adult neural stem cells
(NSCs) and as such adult neurogenesis has fundamentally changed how we
think about the hippocampus; specifically, the mechanism of ongoing neuron
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generation and how this potential for regeneration impacts its function and
dysfunction in neuropsychiatric disorders.
The hippocampal formation is part of the brain’s limbic system and is
involved in spatial navigation and short-term to long-term memory consolidation.
Within the hippocampal formation lies the dentate gyrus, a structure unique in
formation due to unilateral connectivity (Amaral et al., 2007; Jonas and Lisman,
2015; Treves et al., 2008). The dentate gyrus and the CA3 receive significant
input from the entorhinal cortex. The entorhinal cortex projects to the dentate
gyrus via a pathway commonly referred to as the perforant pathway which is
thought to be the first phase in the production of episodic memory. Following the
perforant pathway, the dentate granule cells project to the CA3, termed the
mossy fiber pathway. All dentate granule cells project to the CA3 (Amaral et al.,
2007). Interestingly, only 2-5% of granule cells are active while exploring a novel
environment, indicating a low activity among the mossy fiber pathway’s granule
cell population (Snyder and Cameron, 2012). Additionally, a single granule cell
only synapses with 11-15 CA3 pyramidal cells (Acsády et al., 1998) and multiple
granule cells synapse onto one CA3 pyramidal cell (Amaral et al., 2007).
Importantly, Snyder and Cameron indicated that an individual granule cell can
“trigger firing in downstream CA3 targets” (Snyder and Cameron, 2012) and
since CA3 pyramidal cells form widespread connections with one another it
becomes easy to see that a single granule cell can have a sizeable impact. The
next stage in the hippocampal connectivity pathway (following the mossy fiber
pathway), is the Schaffer collateral pathway, where cells from CA3 project to the
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CA1. Thus the entire hippocampal network involves the entorhinal cortex 
dentate gyrus  CA3  CA1  back to the entorhinal cortex or to the subiculum
(Jonas and Lisman, 2015).
1.3.1 Components of neurogenesis
In the hippocampus, it is now well accepted that new neurons are
generated constitutively throughout life in a multi-step process that originates
from radial glia-like stem cells that reside along the SGZ of the dentate gyrus
(Zhao et al., 2008). Adult hippocampal neurogenesis consists of multiple stages
that cells progress or mature through. Stem-like radial glia act as the NSCs which
can proliferate and generate NPCs which have limited self-renewal and a more
restricted cell fate. NSCs are capable of producing both glial and neuronal NPCs
to generate neurons, glial, or endothelial cells (Bonaguidi et al., 2011, 2012;
Dranovsky et al., 2011; Encinas et al., 2011; Gage, 2000). The NPC term is used
throughout this document when it is not clear which cell type, the NSC or one of
the progenitors, has been examined or if the distinction was not made.
The process of adult neurogenesis begins with Type 1 radial glia-like NSCs
(Figure 1.1). Type 1 cells are located in the SGZ and have vascular end feet
(characteristic of astrocytes), they display morphological and electrophysiological
astrocytic properties, and they express cellular marker combinations unique to
NSCs (Filippov et al., 2003; Kempermann et al., 2015). Type 1 NSCs are
capable of proliferation but tend to divide infrequently and asymmetrically to
generate Type 2 progenitor cells (Figure 1.1 B). Type 2 NPCs are primarily
responsible for the expansion of NPCs because they are highly proliferative
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Figure 1.1 - Drawing of the hippocampal dentate gyrus

Figure 1.1 - Schematic representation of adult neurogenesis and known ways in
which alcohol affects this process. Type 1, Type 2, and Type 3 neural
stem/progenitor cells can be seen along the SGZ located at the intersection of
the GCL and the hilus. Circular arrows indicate that the cell is capable of
replicating. I and M indicate immature neurons and mature neurons, respectively
(Gage, 2000; Zhao et al., 2008). Figure reproduced from Geil et al., 2014.
Alcohol impacts these processes at multiple stages:
(A) Alcohol dependence may kill progenitor cells with long duration, chronic
exposure (Richardson et al., 2009; Taffe et al., 2010).
(B) Alcohol intoxication reduces NPC proliferation whereas reactive increases in
neurogenesis occur one week into abstinence (Nixon and Crews, 2002, 2004).
Alcohol also alters the cell cycle of NPCs (McClain et al., 2011).
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(Figure 1.1 continued)
(C) Multiple ways in which alcohol may directly affect the neurogenic niche,
notably alcohol produces reactive astrocytes and reactive microglia (He et al.,
2005; Kelso et al., 2011; Marshall et al., 2013, 2013).
(D) High peak blood ethanol concentrations are likely required to impact survival
of new born cells (Herrera et al., 2003; Nixon and Crews, 2002).
(E) Chronic alcohol exposure blunted dendritic arborization and impaired
dendritic spine density in newborn cells (Golub et al., 2015; He et al., 2005;
Staples et al., 2015), an effect that would have functional implications for new
cells incorporation into hippocampal circuitry.
(F) Binge alcohol exposure kills entorhinal cortex cells that project to the
hippocampal dentate gyrus (Collins et al., 1996; Kelso et al., 2011).
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(Figure 1.1 C) (Kempermann et al., 2015). Additionally, Type 2 cells are further
differentiated (Type 2a and Type 2b) since these two cell types possess different
cell fates. Type 2 NPCs do not have the radial morphology seen in Type 1 NSCs
but still express the glial/stem cell marker Sox2 (Filippov et al., 2003; Fukuda et
al., 2003; Kempermann et al., 2015). Type 2a NPCs can give rise to Type 2b
NPCs which express neuronal specific markers (ex. NeuroD, DCX, and Prox1),
indicating a neuronal fate (Steiner et al., 2006). Previous research has shown
that the transcription factor Eoms (tbr2) is capable of suppressing Sox2 which is
thought to be important in the transition of NSCs to NPCs with a neuronal fate
(Hodge et al., 2012; Kempermann et al., 2015). As the Type 2b early neuronal
progenitor cells mature they give rise to Type 3 NPCs which continue to express
early neuronal cell markers (ex. NeuroD) and although Type 3 cells are still fully
capable of replicating, it occurs less frequently than it does in the rapidly
multiplying Type 2 cells (Kempermann et al., 2015). NeuroD is a transcription
factor expressed in Type 2b, Type 3, and (early) immature neurons. NPCs exit
the cell cycle becoming postmitotic as they transition from Type 3 cells and
become immature neurons (neuroblasts). Neuroblasts extend axons and
dendrites as they migrate and integrate into the granule cell layer (Sun et al.,
2013). Immature neurons begin to develop dendritic spines when they are
around 16 days old (Zhao et al., 2006). Excitatory synapses are first seen when
cells are 21 days old (Kelsch et al., 2008; Kempermann et al., 2015).
Unsurprisingly, as the neurons mature (into mature granule cells) the dendritic
spines become progressively longer, thicker, and more intricate until neurons are
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around 8-10 weeks old, at which point they plateau (Llorens-Martín et al., 2015a;
van Praag et al., 2002). Interestingly, neurons are considered mature when they
are 28 days old. However, young neurons (~6-8 weeks old), although mature,
have increased synaptic plasticity compared to older neurons (Ge et al., 2007).
When compared to older mature neurons, young neurons require lower
thresholds to induce long-term potentiation (Schmidt-Hieber et al., 2004; Wang et
al., 2000). Furthermore, young mature neurons (6-8 weeks old) can be
preferentially incorporated into hippocampal networks (Kee et al., 2007). Once
the neuronal maturation process is complete (8-10 weeks) the new granule cell
neurons are considered fully integrated into hippocampal circuits and these
neurons can no longer be distinguished from older neurons; they are
electrophysiologically and morphologically identical (Llorens-Martín et al., 2015a,
2015b; Zhao et al., 2006).
1.3.2 Adult neurogenesis and hippocampal function
Adult neurogenesis generates new neurons throughout life. Approximately
6% of the GCL is generated each month in the adult rat (Cameron and McKay,
2001). Although, not every cell that divides survives through incorporation into
the hippocampus. Baseline rates of proliferation, survival, and incorporation vary
across species, strain, age, and sex (Kempermann, 2012; Kempermann and
Gage, 2002a; Zhao et al., 2008). While this phenomenon of adult neurogenesis
is now accepted as a contributor to the structural integrity of the hippocampus
(Imayoshi et al., 2008), the functional role of newborn neurons remains unclear.
Early work relied upon correlation to implicate adult neurogenesis in many of the
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same functions of the hippocampus (van Praag et al., 1999). However,
conditional and inducible transgenic animals have provided the most compelling
evidence for the role of adult neurogenesis. These animals have allowed for the
discovery that adult hippocampal neurogenesis is critical for a computational
process termed pattern separation associated with hippocampal dentate gyrus
(Deng et al., 2010). Pattern separation is a process that acts to enhance
differences between similar experiences so they can be distinguished from one
another (Clelland et al., 2009; Nakashiba et al., 2012). For example, an individual
may park their car in the same garage every day for work but the exact position
of the car is likely to change from day to day. The hippocampus uses pattern
separation to distinguish between today’s parking spot and yesterday’s parking
spot by highlighting subtle differences between the two events. In addition to
transgenic and knock-out animals providing evidence for hippocampal pattern
separation, knock-out animal models have also helped resolve contradictory
results across the hallmark of hippocampal function in rodents, spatial learning
and memory. Well-controlled, genetic manipulations by inducible knockouts or
lentiviral transgene delivery are able to decrease neurogenesis then show, fairly
consistently, impairments in spatial memory (Marin-Burgin and Schinder, 2012).
More importantly, of those that did not detect deficits with the classic test of
spatial memory, the Morris water maze (MWM), several did report impairments in
other hippocampus-dependent behavioral tasks such as contextual fear
conditioning (Saxe et al., 2006), trace fear conditioning (Shors et al., 2002), or
place recognition (Madsen et al., 2003). Therefore, although there are some
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contradictory results, new technologies are helping to resolve these issues to
strengthen the conclusion that decreases in adult neurogenesis result in some
kind of deficit in hippocampal-dependent behavior (Marin-Burgin and Schinder,
2012; Zhao et al., 2008).
1.4 ALCOHOL AND HIPPOCAMPAL NEUROGENESIS
For over 30 years, scientists have speculated that a direct relationship
exists between alcohol intake and disruptions in hippocampal integrity (Walker et
al., 1980). Preliminary conjecture coupled with extensive literature revealing overt
cell death following alcohol exposure in vivo led to the original assumption that
cell loss in the hippocampus was the result of dying neurons (Bengochea and
Gonzalo, 1990; Collins et al., 1996; Walker et al., 1980). However, this theory
failed to incorporate the then controversial idea that adult neurogenesis was an
essential component of hippocampal structure and function (Zhao et al., 2008). In
fact, more recent data utilizing adult and adolescent alcohol exposure models
strongly suggest that alcoholic neuropathology is at least partially due to an
attenuation of adult neurogenesis (Crews et al., 2006b; Morris et al., 2010a;
Nixon and Crews, 2002). In this same 4-day binge model of an AUD,
hippocampal integrity is impacted, resulting in an 16% loss of granule cells
despite a lack of equivalent levels of cell death (Leasure and Nixon, 2010).
Therefore, alcohol likely impairs hippocampal integrity, in part, through its effects
on adult neurogenesis (Morris et al., 2010a). As described above, adult
neurogenesis is a process comprised of multiple components: cell proliferation,
differentiation, migration, and survival/integration. Alcohol exposure can affect
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neurogenesis at any one of these individual phases or through a combination of
effects at multiple stages (Figure 1.1). Indeed, the various phases are
differentially affected by alcohol intoxication, alcohol dependence, and other
sequelae that result from chronic alcohol exposure such as seizures and/or
neurodegeneration. Therefore, the effects of alcohol intoxication versus alcohol
withdrawal and abstinence are discussed separately. The majority of in vivo
studies have shown that alcohol intoxication leads to an overall decrease in
neurogenesis through alcohol's effects on cell proliferation and cell survival
(Anderson et al., 2012; Crews and Nixon, 2009; Golub et al., 2015; Herrera et al.,
2003; Jang et al., 2002; Nixon and Crews, 2002; Pawlak et al., 2002; Richardson
et al., 2009; Taffe et al., 2010), while increased neurogenesis has been observed
in abstinence following alcohol dependence (He et al., 2009; Nixon and Crews,
2004). Although a few studies showed no effect or an increase in proliferation
resulting from 10 days (Rice et al., 2004), 2 weeks (Aberg et al., 2005), 6 weeks
(Herrera et al., 2003), or 10 weeks (Aberg et al., 2005) of chronic alcohol
exposure, these differences could result from the use of different animal models,
the animal's BEC at time of sacrifice/analysis, the timing of analysis with respect
to alcohol exposure, and methods used to label proliferating cells (Nixon, 2006).
Despite all of these explanations, an interesting trend can be observed from
these reports: ethanol intoxication appears to dose-dependently inhibit NSC
proliferation. This dose-dependency is noted since low BECs appear to increase
NSC proliferation (Aberg et al., 2005), while higher doses decrease it (Nixon,
2006). This dose-dependent effect has been shown in vivo with acute doses in
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adolescent rats (Crews et al., 2006b) and can be extrapolated from a similar
correlation in mice (Contet et al., 2014). Determining or estimating the BEC at the
time of sacrifice and labeling of the proliferating population continues to support
the view that some level of significant intoxication, perhaps above 80 mg/dl, is
necessary to inhibit proliferation (Aberg et al., 2005; Crews et al., 2006b; Nixon,
2006). Recent publications continue to support this point. For example, rats that
were fed an ethanol containing liquid diet had an average BEC of 86.4 mg/dl
(0.08%) and showed a 40% decrease in proliferation (Anderson et al., 2012). It is
important to note that these BECs were obtained from animals at sacrifice, which
is typically done during lights on, at the start of the sleeping period for rodents,
and thus 12+ hours past when they would likely have had a drinking bout and
BECs would have peaked. Therefore, alcohol may have reduced proliferation in
some of these divergent studies, but the sacrifice time point missed the time of
peak intoxication and therefore peak inhibition of cell proliferation. Alternatively, it
is of note that the two studies that have observed an increase in proliferation
have been in mice (Aberg et al., 2005; Pawlak et al., 2002). Interestingly, Snyder
and colleagues showed that when compared to mice, rats generally had more
adult born neurons that matured quicker and were more involved in behavior
(Snyder et al., 2009). Mice also catabolize ethanol much faster than rats (Livy et
al., 2003), meaning withdrawal events will occur relatively earlier.
A few studies have observed persistent decreases in proliferation despite
animals being days to weeks past their last exposure and therefore no longer
significantly intoxicated. The number of bromodeoxyuridine- and Ki76-positive
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cells (exogenous and endogenous proliferation markers, respectively) remains
decreased compared to controls in these reports, but it is worth noting that the
majority of these reports were from long-term chronic exposure models with
weeks or months of ethanol exposure (Broadwater et al., 2014; Contet et al.,
2014; Hansson et al., 2010; Richardson et al., 2009; Taffe et al., 2010).
Therefore, the duration (i.e. number of days, whether repeated binge-like or
chronic) may impact the number of proliferating progenitors. Alcohol also
potentially kills NSCs and/or NPCs according to long-term alcohol dependence
models, again highlighting that dose and duration of exposure may be critical
factors in understanding the mechanism of alcohol's effects on NSCs, NPCs, and
adult neurogenesis (Contet et al., 2014; Hansson et al., 2010; Nixon and Crews,
2002; Richardson et al., 2009; Taffe et al., 2010).
Although hippocampal NPC proliferation is decreased during alcohol
intoxication, the percentage of newly born cells that differentiate into neurons or
glia appears unchanged. However, no studies have examined differentiation
specifically. Several intriguing reports on alcohol induced effects in human NSCs
within the context of Fetal Alcohol Spectrum Disorders (Vangipuram and Lyman,
2010; Zhou et al., 2011) suggest that differentiation might be a potential area for
discovery in AUD models. NPC/neuroblast survival is generally decreased in
alcohol exposure models, but again, this effect is heavily dose dependent, i.e.,
higher doses of alcohol produce greater decreases in new cell survival (Nixon
and Crews, 2002; Richardson et al., 2009). This dose and duration dependency
is not surprising as alcohol-induced neuronal cell death, in general, is also
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hypothesized to be dose and duration dependent. Several groups, including ours,
speculate that sustained BECs greater than 200 mg/dl (0.20%) are necessary to
produce neurodegeneration (Collins et al., 1996). In support of this idea, a single
5 g/kg dose of alcohol, which only transiently produces >0.20% BEC, does not
inhibit survival of hippocampal NPCs (Nixon and Crews, 2002).
In addition to alcohol affecting proliferation, it also affects the developing
dendritic arbors of immature post-mitotic neurons (Figure 1.1 E). Chronic alcohol
consumption decreases the number, size, and thickness of dendrites in new
neurons, effectively blunting dendritic arborization (Golub et al., 2015; He et al.,
2005). This dendritic blunting likely has functional implications as young neurons
become incorporated into the hippocampal circuitry since the number of
dendrites (connections) are reduced. Reduced neural connectivity can result in
impaired neuronal processing ability.
1.5 ALCOHOL AND REACTIVE NEUROGENESIS
Here the process of neurogenesis is described using the general term
neurogenesis (which encompasses all stages of neurogenesis: proliferation,
differentiation, migration, and maturation), or using the more specific term,
proliferation (which refers only to the proliferation stage of the neurogenesis
process). Although chronic alcohol intoxication inhibits multiple aspects of adult
neurogenesis, a different set of effects on adult neurogenesis are observed in
abstinence after intoxication. The most distinct change involves a large, transient
(reactive) increase in NPC proliferation seen well after the cessation of alcohol
exposure in both binge and chronic alcohol models. Specifically, in a 4-day binge
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model of alcohol dependence, a burst in NPC proliferation (called reactive
proliferation) occurs after one week of abstinence, leading to an increased
number of newly formed mature neurons four weeks later (Nixon and Crews,
2004). Notably, proliferation returns to control levels by at least two weeks
following the last ethanol dose, which emphasizes the short-lived nature of the
reactive neurogenesis response (Nixon et al., 2008). Similar increases in NPC
proliferation and neurogenesis in abstinence have been described in alcoholpreferring rats subjected to a seven-week two bottle choice paradigm and in rats
exposed chronically to ethanol via vapor chambers (Hansson et al., 2010; He et
al., 2009). In contrast, Taffe and colleagues reported a decrease in NPC
proliferation and neurogenesis after two months of abstinence in adolescent
rhesus macaques given alcohol chronically for 11 months (Broadwater et al.,
2014; Taffe et al., 2010).This discrepancy may involve several factors related to
the vastly different models: species of the animals, the time in abstinence that
was analyzed, and possibly even the age of the animals. In addition, given the
transient nature of reactive neurogenesis observed early in abstinence in rodent
models of alcohol exposure, it is possible that a similar transient change occurred
but was missed due to the timing of analysis (which was months into abstinence).
Importantly, if a short-lived increase in neurogenesis was missed, the
subsequent return to an overall decrease in neurogenesis represents a potential
barrier to full recovery of hippocampal structure and function. For this reason,
understanding the mechanisms responsible for reactive neurogenesis may be
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important for designing strategies aimed at sustaining neurogenesis at normal
levels after long-term abstinence (Mandyam and Koob, 2012).
The specific components and the degree to which each stage of adult
neurogenesis is affected by alcohol depend upon the dose, duration, and pattern
of alcohol exposure as well as the age of the organism (Nixon, 2006). The
mechanisms of alcohol induced effects on neurogenesis have yet to be
described and remain a critical gap in understanding the role of alcohol-induced
brain damage in AUDs. In the following section, select plausible interactions are
discussed through which alcohol may exert its effects on adult neurogenesis.
1.6 POTENTIAL MECHANISMS OF ALCOHOL'S EFFECTS ON ADULT
NEUROGENESIS
Excessive consumption of alcohol results in behavioral and neurochemical
changes that are difficult to isolate due to the promiscuous pharmacology of
ethanol on the brain. Ethanol's effects range from direct modulation of many
neurotransmitter systems to indirect outcomes that are caused by or are
comorbid with alcohol dependence. Alcohol's effects also vary depending on
dose and duration of exposure, especially noting that a variety of
neuroadaptations occur with the development of dependence (Vengeliene et al.,
2008). Here, the direct effects of ethanol on neurotransmission are summarized.
However, it is likely that neurotransmission, cell signaling, and ethanol’s cellular
effects on the neurogenic niche all interact with each other as well as the host of
indirect effects/comorbidities to generate the net effect alcohol has on the
components of hippocampal adult neurogenesis.
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Ethanol affects virtually every neurotransmitter system in the CNS
(Vengeliene et al., 2008). For example, concentrations of alcohol that reflect
those seen in human consumption may directly interact with a host of
neurotransmitters, receptors and ion channels including acetylcholine,
endocannabinoids, neuropeptide Y (NPY), gamma-aminobutyric acid (GABA)
receptors, glutamate receptors, dopamine receptors, and serotonin receptors
along with G-protein-activated inwardly rectifying K+ channels (Arnone et al.,
1997; Fadda and Rossetti, 1998; Grobin et al., 2001; Lewohl et al., 1999;
Lovinger, 1999; Lovinger et al., 1989; Vengeliene et al., 2008). This list notably
overlaps with the neurotransmitter systems that regulate adult hippocampal
neurogenesis, including acetylcholine, endocannabinoids, GABA, glutamate,
norepinephrine, NPY, and serotonin to name a few (Aguado et al., 2005; BruelJungerman et al., 2011; Cameron et al., 1998; Conover and Notti, 2008; Gray,
2008). As many of these have been reviewed previously (Crews and Nixon,
2003; Nixon et al., 2010, 2011), only the primary targets GABA and glutamate
are discussed below.
The process of adult neurogenesis and maturation of newly born neurons
involves two neurotransmitter systems that are also considered the primary
pharmacodynamic targets of ethanol, GABA and glutamate. GABAA receptors
are present on newly born neurons in the SGZ and GABA acts as an excitatory
neurotransmitter during the first two - four weeks of new neuron development
(Esposito et al., 2005; Ge et al., 2006; Overstreet Wadiche et al., 2005). Around
this time, the neuron begins to express NMDA receptors and undergoes a switch
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from GABA being excitatory to inhibitory and NMDA being excitatory,
recapitulating that seen in development (Nacher et al., 2007; Zhao et al., 2008).
Previous studies show that treatment with a GABAA agonist results in decreased
SGZ NPC proliferation while antagonist treatment yielded the opposite effect
(Tozuka et al., 2005). However, treatment with a GABAA agonist was shown to
enhance activity-dependent neuronal differentiation (Tozuka et al., 2005). Since
ethanol is a positive allosteric modulator of the GABAA receptor it is possible that
this receptor could be one avenue through which alcohol acts to alter
neurogenesis. These findings also suggest that alcohol could have very specific
effects on NPCs and developing neuroblasts depending on their state of
ontogeny, especially when GABA is initially excitatory. However, no one has
explored this potential relationship or whether alcohol affects the maturation of
neuroblasts in the dentate gyrus.
The role of NMDA receptors in adult neurogenesis is complex. Several
studies have shown that NMDA receptor activation inhibits adult hippocampal
neurogenesis (Cameron et al., 1995; Maekawa et al., 2009; Nacher et al., 2001;
Pava and Woodward, 2012); whereas NMDA receptor antagonism increases
adult neurogenesis (Cameron et al., 1995; Petrus et al., 2009). Acutely, ethanol
intoxication inhibits NMDA receptors (Lovinger et al., 1989) which indicates that
NMDA receptors are not likely the mechanism by which ethanol intoxication
decreases adult neurogenesis (Nixon and Crews, 2002). Prolonged ethanol
exposure and the development of dependence, however, augments NMDA
function and enhances glutamate release, both of which contribute to neuronal
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hyperexcitability associated with the ethanol withdrawal syndrome (Hoffman,
2003). Increased neurogenesis is observed after four days of ethanol inhibition of
NMDA receptors, which is consistent with an NMDA antagonist similarly
increasing neurogenesis (Cameron et al., 1995). Furthermore, ethanol
withdrawal-induced hyperexcitability increases activation of granule cell neurons
as measured by c-Fos immunoreactivity (Knapp et al., 1998; Matsumoto et al.,
1993). Although hyperexcitability associated with ethanol withdrawal typically
subsides within 24 hours (Matsumoto et al., 1993), previous studies demonstrate
that the effects of granule cell excitation on neurogenesis can be delayed by
several days (Bruel-Jungerman et al., 2006; Stone et al., 2011a). Additional
studies are needed, but the delayed neurogenic effects associated with activitydependent neurogenesis fit the temporal profile for reactive neurogenesis that
occurs after a 4-day binge ethanol exposure (Nixon and Crews, 2004).
Seizures have been shown to result in increased levels of neurogenesis
(Parent et al., 1997). Seizures can also occur during alcohol withdrawal and
therefore represent a potential confound. However, this issue has been
addressed in studies utilizing a 4-day binge model of an AUD. Using diazepam,
researchers were able to significantly reduce the number of rats that experienced
alcohol withdrawal-induced seizures as indicated by decreased withdrawal
severity scores (Nixon and Crews, 2004). Proliferation levels were assessed
seven days post-binge, when an increase is normally seen in this model, and
even when withdrawal severity was reduced, there was still a significant increase
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in proliferation over controls (Nixon and Crews, 2004). Therefore, withdrawalinduced seizure is not a confounding variable.
1.7 CONCLUSION
Numerous studies have illustrated that AUDs result in damage to the CNS
with the hippocampus being one of the targets of its neurotoxic effects. Recent
preclinical studies have highlighted that alcohol's effects on the various
components of adult neurogenesis are one way in which excessive alcohol intake
produces hippocampal pathology. By impacting the structure and function of the
dentate gyrus through inhibition of adult neurogenesis, alcohol has downstream
effects on hippocampal circuitry and subsequently the host of behaviors
controlled or influenced by the hippocampus. Importantly, research has shown
that some recovery is possible when alcoholics abstain from alcohol use (Bartsch
et al., 2007; Carlen et al., 1978; Pfefferbaum et al., 1995; Shear et al., 1994).
Although there are a host of plastic changes that occur with abstinence, one way
that the hippocampus may recover in abstinence is through the repopulation of
the dentate gyrus by adult neurogenesis. Although it has been reported that a
compensatory increase in neurogenesis occurs in abstinence, it is still not known
whether the new cells are correctly integrated or the extent to which this process
influences cognitive recovery. Despite observation of this potential mechanism of
recovery in animal models, detectable cognitive impairments remain in over 50%
of AUD cases (Eckardt and Martin, 1986; Parsons, 1993). Therefore, important
future questions should be aimed at understanding 1) alcohol-induced decreases
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in pathology, 2) reactive neurogenesis following alcohol exposure in recovery,
and 3) hippocampal integrity and function in AUDs.
1.8 DISSERTATION OBJECTIVES
As described above, reactive neurogenesis is the process by which
central nervous system (CNS) injury yields an increase in neurogenesis, and is a
potentially beneficial endogenous mechanism of brain recovery. At this time, the
role of alcohol-induced reactive neurogenesis in hippocampal recovery is not
known. However, since alcohol intoxication reduces proliferation and then
cessation of alcohol results in an increase in proliferation/neurogenesis, we
hypothesize that this reactive neurogenesis promotes the functional recovery of
the dentate gyrus following alcohol exposure. To investigate the functional
contribution that reactive neurogenesis makes to hippocampal recovery it was
necessary to reduce reactive neurogenesis to basal neurogenesis levels (which
are seen in control animals, throughout life). This study was designed to a)
expose rats to a binge model of an AUD that results in reactive neurogenesis, b)
inhibit reactive neurogenesis (with alcohol or drug), and then c) determine how a
lack of reactive neurogenesis affects hippocampal recovery (measured with the
MWM). This study was designed with the overall goal of assessing the behavioral
effect of essentially eliminating reactive neurogenesis. To that end, Chapter 2
detailed the results of inhibiting reactive neurogenesis using a secondary alcohol
exposure since acute high doses of alcohol are anti-proliferative (Nixon and
Crews, 2002). Remarkably, this secondary alcohol exposure did not inhibit
reactive proliferation. In trying to understand these negative results it was
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postulated that perhaps reactive neurogenesis begins prior to when the
secondary dose of alcohol was administered and that this may underlie why
reactive neurogenesis was so robust and resistant to suppression. Regardless,
these negative results emphasized the lack of knowledge regarding the timing of
alcohol-induced reactive neurogenesis, which necessitated a thorough
investigation into when, exactly, the increase in reactive proliferation began.
Chapter 3 addressed this issue by investigating the time course of alcoholinduced reactive proliferation. The goal of these experiments was to pinpoint the
day proliferation began to increase (in ethanol rats compared to controls) so that
future experiments could target it to reduce reactive proliferation to basal
proliferation levels. Based on this newly established time-course, Chapter 4
determined the optimal dose of the antimitotic temozolomide needed to attenuate
alcohol-induced reactive proliferation/neurogenesis in the dentate gyrus.
Additionally, the functional implications of inhibiting reactive neurogenesis were
examined by investigating changes in MWM performance. The last chapter,
Chapter 5 investigated activation of young neurons. Following training on the
hippocampal-dependent task, functional incorporation was assessed via
activation of granule cells born during alcohol-induced reactive neurogenesis.
The proposed studies are critical in evaluating the role of alcohol-induced
reactive neurogenesis in recovery from AUDs. Furthermore, these studies
provided valuable insight into modulation of the NPC pool as a potential
therapeutic target for the treatment of AUDs.
Copyright © Chelsea Rhea Geil Nickell 2016

31

CHAPTER 2: INHIBITION OF REACTIVE PROLIFERATION WITH ETHANOL
2.1 INTRODUCTION
Excessive alcohol consumption, characteristic of an AUD, results in
neurodegeneration in brain regions such as the hippocampus (Beresford et al.,
2006; Wilhelm et al., 2008). With abstinence from alcohol use there is some
recovery seen in human brain volume and function (Bartels et al., 2007;
Pfefferbaum et al., 1995). However, the mechanisms involved in recovery are
poorly understood (Nixon, 2006). Adult hippocampal neurogenesis is the process
by which neural progenitor cells (NPCs) proliferate in the SGZ, differentiate,
migrate, and integrate as granule cells into the GCL of the hippocampal dentate
gyrus (Ming and Song, 2011). The functional significance of adult neurogenesis
remains a subject of debate. Many, however, think it is critical for normal
hippocampal function (Braun and Jessberger, 2014). Ethanol intoxication inhibits
adult neurogenesis, specifically, the proliferation of NPCs and cell survival,
depending on the extent of exposure, which is thought to contribute to behavioral
impairments in hippocampal-dependent tasks such as the MWM following a
binge model of an AUD (Nixon and Crews, 2002; Obernier et al., 2002b).
Conversely, after seven days of abstinence (T7) from a binge model of an AUD
there is a reactive increase in NPC proliferation which may contribute to recovery
of hippocampal function (Nixon, 2006; Nixon and Crews, 2004).
The functional significance of alcohol-induced reactive neurogenesis has
not been investigated (Geil et al., 2014; Richardson et al., 2009). Currently, it is
not known if this reactive neurogenesis contributes to improvements in

32

hippocampal-dependent tasks seen during abstinence. To that end, this
experiment was designed to decrease alcohol-induced reactive neurogenesis so
that hippocampal-dependent behavioral testing could help determine if alcoholinduced reactive neurogenesis is required for recovery of hippocampal function.
Previously, it has been shown that ethanol exposure affects a variety of
organ systems (Manzo-Avalos and Saavedra-Molina, 2010). This includes the
nervous system in general and the neurogenic region of the hippocampus (Jang
et al., 2002; Nixon and Crews, 2002; Richardson et al., 2009). Specifically, a
single high dose of ethanol (5 g/kg) administered via gavage significantly
reduced proliferation in the SGZ of ethanol-naïve rats (Nixon and Crews, 2002).
Therefore, in this study, two doses of ethanol (5 g/kg) were administered to
decrease alcohol-induced reactive proliferation. This study tests the hypothesis
that alcohol (administered six days after the end of a 4-day binge alcohol
exposure) would decrease alcohol-induced reactive proliferation.
2.2 METHODS
2.2.1 Binge model of an alcohol use disorder
Twenty-eight adult male Sprague-Dawley rats (Charles River Laboratory;
approximately PND 70) weighing 275-300 g on arrival were used in the following
experiment. A total of six rats were excluded from analysis because they failed to
incorporate BrdU; three rats were removed from the C+C (control + control)
group, one from the E+C (ethanol + control) group, and three from the E+E
(ethanol + ethanol) group. Groups described in detail on page 40. This
experiments primary outcome measure was to assess proliferation with BrdU+

33

staining which is not possible when rats to not take up the injected BrdU.
Reported results are based on the 22 rats that successfully incorporated BrdU.
All rats were allowed to acclimate to the vivarium for five days before
alcohol exposure began. All experimental procedures were completed in
accordance with the University of Kentucky Institutional Animal Care and Use
Committee and followed the Guidelines for the Care and Use of Laboratory
Animals (NRC, 1996). The vivarium was temperature and humidity controlled and
allowed 12 hours of lights-on at 6:00 AM, and 12 hours lights-off at 6 PM. Upon
arrival, animals were housed 2/cage and allowed ad libitum access to rat chow
and water at all times except during the four days of binge alcohol exposure
when rat chow was removed. While rats became acclimated to their new
environment they were individually handled for three minutes a day for three
days to familiarize the rats with being held. On their sixth day in the animal
vivarium, rats were subjected to a 4-day rodent binge model of an AUD that
achieves high blood alcohol concentrations (BACs) and produces tolerance,
physical dependence, and corticolimbic neurodegeneration with low mortality
(Collins et al., 1996; Crews et al., 2000; Majchrowicz, 1975; Nixon and Crews,
2004). This binge model of alcohol consumption was chosen because up to 60%
of human alcoholics consume alcohol in a binge pattern (Robin et al., 1998).
Furthermore, this model produces high BACs similar to those observed in human
alcoholics (Cartlidge and Redmond, 1990; van Hoof et al., 2011; Lindblad and
Olsson, 1976). This model maintains high blood alcohol levels and induces
alcohol-induced reactive neurogenesis (Nixon and Crews, 2004).
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This model of binge alcohol exposure has been described previously and
in detail (Majchrowicz, 1975; Nixon and Crews, 2004). Briefly, rats were
randomly divided into three groups with similar starting weights and were
gavaged with either 25% (w/v) ethanol in Vanilla Ensure Plus® (Abbott
Laboratories, Columbus, OH) or an isocaloric control diet (made calorically
equivalent with dextrose) in Vanilla Ensure Plus®. Ethanol or control diet was
administered via gavage every eight hours for four days. Ethanol animals were
initially given a 5 g/kg ethanol dose and all subsequent doses were titrated based
on the animal’s behavioral intoxication score according to the scale in Table 2.1
(Majchrowicz, 1975; Nixon and Crews, 2004). The desired clinical effect is
alcohol intoxication resulting in consistent blood alcohol concentrations with
minimal mortality (Collins et al., 1996; Knapp and Crews, 1999). Essentially,
dosages are adjusted to achieve a desired clinical effect. According to the dosing
scale, less intoxicated rats (e.g. hypoactive and mildly ataxic) receive more
alcohol than rats showing stronger behavioral signs of intoxication (e.g. loss of
righting reflex while maintaining the eye blink reflex). Each rat that receives
alcohol is individually scored for behavioral intoxication and then the
corresponding dose of ethanol is administered via gavage. The average volume
of diet given to the ethanol animals was determined and that volume of isocaloric
control diet was given to all control animals. This ensured that control and
ethanol rats receive approximately the same number of calories. Food restriction
has been shown to be associated with changes in neurogenesis in some models
(Barbarich-Marsteller et al., 2013; Park and Lee, 2011). However, previous
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Table 2.1 - Behavioral intoxication and dosing scale
Intoxication
score
0
1
2
3
4
5

Behavioral features
Normal animal
Hypoactive, mildly ataxic
Ataxic, elevated abdomen
Ataxic, no abdominal elevation,
delayed righting reflex
Loss of righting reflex, maintain
eye blink reflex
Loss of righting reflex, loss of
eye blink reflex

Ethanol
dose
(g/kg)
5
4
3
2
1
0

Table 2.1 - Animals were assessed based on their behavioral features and
intoxication scores were used to calculate the appropriate dose of ethanol for
administration. This modified Majchrowicz scale indicates proper ethanol dose
based on behavioral intoxication (Majchrowicz, 1975; Morris et al., 2010a; Nixon
and Crews, 2004).

36

studies have shown that free-feeding rats (un-handled, ad libitum controls) and
control diet rats (food restricted to match ethanol rat’s caloric intake) showed no
differences in neurogenesis (Nixon and Crews, 2002). All animals were weighed
daily during alcohol administration since dosing calculations are based on animal
weight.
The ethanol groups underwent monitored withdrawal for 17 hours
beginning 10 hours after the last dose of ethanol (Morris et al., 2010a). This time
frame was selected because it is associated with peak alcohol withdrawal
symptoms (Faingold, 2008; Majchrowicz, 1975; Nixon and Crews, 2004; Penland
et al., 2001). Rats were observed for 30 minutes every hour for 17 hours and
withdrawal behavior was scored using a Majchrowicz behavioral withdrawal scale
(Table 2.2) modified by Penland et al. 2001 (Morris et al., 2010a). Behaviors
were assigned a numerical score according to severity, where higher scores
indicated increased withdrawal severity. The highest rated behavioral feature
was determined for each 30 minute interval. For example, if from 10:00-10:30 PM
an animal had splayed limbs (score of 2.4) and a head tremor (score of 3.0), then
the highest score (a 3.0, head tremor) was recorded for that animal at that time
point. Peak withdrawal score was also analyzed for each rat and consists of the
highest withdrawal score observed at any time point across the entire 17 hour
withdrawal period. Mean and Peak withdrawal scores are calculated across all
animals and are expressed as mean withdrawal score and peak withdrawal score
± standard error of the mean.
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Table 2.2 - Behavioral withdrawal scale
Withdrawal
score
1.0
1.4
1.6
2.0
2.2
2.4
2.6
3.0
3.2
3.4
3.6
3.8
4.0

Behavioral
feature
Hyperactivity
Tail Tremor
Tail Spasm
Caudal Tremor
Tip-Toe Arch
Splayed Limbs
General Tremor
Head Tremor
Induced Running
Wet Dog Shakes
Teeth Chattering
Spontaneous Convulsions
Death

Table 2.2 - Withdrawal scores are an index of withdrawal severity and were
quantified using this scale (Morris et al., 2010a).

38

2.2.2 Blood ethanol concentration
Ninety minutes following the seventh dose of ethanol, tail bloods were
collected to determine peak blood ethanol concentration (BEC; Morris et al.,
2010b). Blood samples were centrifuged at 1,800 x g for five minutes to separate
blood plasma from red blood cells and then stored at -20º C until processing. To
quantify BECs, 5 µl supernatant blood serum was inserted into an AM1 Alcohol
Analyzer (Analox Instruments, Lunenberg, MA). All blood serum samples were
run in triplicate with frequent calibration to a 300 mg/dl ethanol standard. Data
are presented as mean blood ethanol concentration ± standard error of the
mean.
2.2.3 Ethanol-induced inhibition of reactive proliferation
Previous studies showed that a single dose of 5 g/kg ethanol reduced
proliferation in ethanol-naïve rats (Nixon and Crews, 2002). Since the rats in the
present study were not ethanol-naïve, they were given an additional 5 g/kg dose
of ethanol (for a total of 2 doses). This second dose was added because we
hypothesized that alcohol-induced reactive proliferation would be more difficult to
inhibit than basal proliferation in ethanol-naïve rats. Furthermore, if a single dose
of ethanol did not decrease reactive proliferation then it would have likely
required an additional experiment with multiple doses of ethanol. Consequently,
in an effort to reduce the number of animals used to inhibit alcohol-induced
reactive proliferation, rats were administered two 5 g/kg doses of ethanol
beginning on the sixth day of abstinence (T6), following the 4-day binge (Figure
2.1). The first additional dose of ethanol was administered at the end of T6 and

39

the second dose was given eight hours later at the beginning of T7.
Rats underwent either (a) standard 4-day binge with control diet (dextrose
in Vanilla Ensure Plus®) + two doses of control diet on T6/7 (Control + Control,
C+C), or (b) standard 4-day binge with ethanol diet + two doses of control diet on
T6/7 (Ethanol + Control, E+C), or (c) standard 4-day binge with ethanol diet + two
doses of 5 g/kg ethanol (25% w/v) in Vanilla Ensure Plus® (Ethanol + Ethanol,
E+E). Groups are outlined in Table 2.3.
2.2.4 Tissue preparation
Seven days after the 4-day binge, animals were injected (i.p.) with a
saturating dose (Cameron and McKay, 2001) of bromodeoxyuridine (300 mg/kg
BrdU; Roche, Mannheim, Germany) in 0.9% saline. The proposed dose of BrdU
has been shown not to result in toxicity or to label DNA repair via IHC methods
(Cameron and McKay, 2001; Palmer et al., 2000). Two hours after BrdU
injections, all rats were administered a lethal dose of sodium pentobarbital (i.p.;
Fatal-Plus®, Vortech Pharmaceuticals, Dearborn, MI) and transcardially perfused
using 0.1 M phosphate buffered saline (PBS) followed by 4% paraformaldehyde
(PFA). Brains were removed and post-fixed for 24 hours in 4% PFA. Brains were
then cut into 40 µm thick coronal sections on a vibrating microtome (Leica
VT1000S, Wetzlar, Germany) and collected in a 1:12 series. Tissue sections
were stored in 24-well plates with cryoprotectant at -20° C until processing.
2.2.5 Bromodeoxyuridine immunohistochemistry
IHC was performed on free floating sections in a 1:6 series as previously
described (McClain et al., 2011; Nixon and Crews, 2002). Sections were rinsed in
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Table 2.3 - Groups for additional ethanol administration experiment
Treatment
C+C
E+C
E+E

4-Day binge
Control
Ethanol
Ethanol

Additional
Control
Control
Ethanol

n
8
6
8

Table 2.3 - Rats received four days of ethanol diet or isocaloric control diet
followed by two additional doses of either 5 g/kg ethanol diet or control diet.
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Figure 2.1 - Ethanol administration to reduce reactive proliferation

Figure 2.1 - Experimental timeline. Additional doses of 5 g/kg ethanol (or
isocaloric control) were given to decrease alcohol-induced reactive cell
proliferation.
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tris-buffered saline (TBS) between each incubation step (day one, 2 x 5 minutes
and day two, 3 x 10 minutes, unless otherwise noted). Sections were incubated
in 0.6% hydrogen peroxide for 30 minutes, rinsed 3 x 5 minutes in TBS, followed
by incubation in antigen retrieval with standard sodium citrate (SSC) and 50%
formamide for 2 hours at 65° C. Then tissue was rinsed in 2X SSC for 2 x 5
minutes, incubated in 2N HCl for 1 hour at 37° C to denature DNA, and was
neutralized in 0.1 M boric acid, pH 8.5 for 2 x 5 minutes. Tissue was rinsed for 3
x 3 minutes in TBS and was incubated for 30 minutes in blocking buffer (3%
serum/0.1% Triton X-100/TBS) with normal horse serum (Vector Laboratories,
Burlingame, CA). Tissue was rinsed in reaction buffer (0.1 g MgCl in 500 ml
TBS), incubated for 1 hour in DNAse 100U/1 ml (in reaction buffer),
rinsed/incubated in blocking buffer 2 x 5 minutes, and incubated in primary
antibody overnight (1:5000 mouse anti-BrdU, MAB 3424 Millipore, Billerica, MA).
The following day tissue was rinsed in blocking buffer 3 x 10 minutes, followed by
incubations in biotinylated horse anti-mouse secondary antibody for 1 hour at
room temperature (Vector Laboratories, Burlingame, CA), avidin-biotin-complex
for 1 hour at room temperature (ABC Elite Kit, Vector Laboratories, Burlingame,
CA), and processed with nickel-enhanced 3,3’-Diaminobenzidine for visualization
(DAB, Polysciences, Warrington, PA). Tissue was then washed in TBS (to
quench the reaction) for 3 x 5 minutes. All sections were mounted onto glass
slides and allowed to dry overnight. Sections were then lightly counterstained
with cresyl violet (Acros Organics, Morris Plains, New Jersey): mounted tissue
was rehydrated through decreasing concentrations of ethanol followed by
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distilled water (dH2O) and cresyl violet (0.1% in Walpole buffer) for 3 minutes.
After differentiation in dH2O, tissue was then dehydrated in increasing
concentrations of ethanol followed by clearing in xylenes (Leasure and Nixon,
2010; Nixon and Crews, 2002). Glass coverslips and Cytoseal® (Stephens
Scientific, Wayne, NJ) were used to seal the slides.
2.2.6 Quantification
All slides were coded to ensure the experimenter was blind to the
treatment conditions. BrdU+ cells were counted between Bregma -2.28 mm and
-5.52 mm as determined by Paxinos and Watson (2009). Prior to quantification,
all sections were inspected to determine which hemisphere was most intact and
would therefore be best to count cells in. Cells were then counted along the SGZ,
a band of cells approximately three cell widths that runs between the GCL and
the hilus of the hippocampal dentate gyrus. Cells were counted using a 100x
objective lens hooked up to an Olympus BX41 microscope (Olympus, Center
Valley, PA). On the anterior portion of the hippocampus the dentate gyrus is a
single blade, to account for this, the blades were quantified separately then the
averages were totaled across all sections. Data are expressed as average
cells/section ± standard error of the mean. Since proliferating cells expressing
BrdU at this time point are located in clusters scattered unevenly throughout the
SGZ, cell profiles were counted. Cell profile counts were more appropriate here
since unbiased stereology requires evenly distributed cells in excess of 200
cells/section and those conditions are not met with BrdU proliferation studies so it
was more appropriate to use profile cell counts (Crews et al., 2004b; Noori and
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Fornal, 2011). Additionally, an identical percent change is obtained by this profile
counting method when compared to stereology (Crews et al., 2004b).
2.2.7 Statistics
All data were analyzed with GraphPad Prism® (version 7.0, GraphPad
software, La Jolla, CA) using a one-way ANOVA followed by Tukey’s multiple
comparison tests. Intoxication data was analyzed by comparing treatment groups
using the student’s t-test (ethanol dose and BEC) or the nonparametric, MannWhitney test (intoxication scores and withdrawal scores). P-values were
accepted as significant when p < 0.05 (two-tailed).
2.3 RESULTS
2.3.1 Animal model data
Data were collected to assess intoxication between treatment groups and
are detailed in Table 2.4. Animals treated with ethanol had an average
intoxication score of 1.7 ± 0.1 on the 6-point intoxication scale (Table 2.4), which
is expressed behaviorally as ataxia with an elevated abdomen. Intoxication
scores resulted in animals receiving a total of 10 ± 0.3 g/kg/d ethanol, and
corresponded to an average BEC of 366 ± 20 mg/dl. These values are similar to
those previously reported (Morris et al., 2010). Student’s t-tests revealed no
differences between the treatment groups in terms of dose and BEC. The MannWhitney test also revealed no differences between the treatment groups when
comparing intoxication scores. Intoxication was assessed only for the 4-day
binge. The 4-day binge doses were titrated based on intoxication behavior, while
the ethanol doses to decrease reactive proliferation (post-binge) were kept
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Table 2.4 - Four-day binge intoxication data
Treatment
Intoxication
group
score
Ethanol + Control
1.6 ± 0.2
Ethanol + Ethanol
1.7 ± 0.1

Dose
(g/kg/day)
10.3 ± 0.6
9.8 ± 0.4

BEC
(mg/dl)
354 ± 24
375 ± 31

n
6
8

Table 2.4 - Intoxication parameters show average intoxication scores, ethanol
dose, and BEC for ethanol animals during a 4-day binge treatment; all treatment
groups were statistically similar.
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constant at 5 g/kg to maintain consistent effects on proliferation. As such,
treatment groups in Table 2.4 and 2.5 represent intoxication behavior during the
4-day binge treatment only.
2.3.2 Intoxication withdrawal data
Withdrawal scores were assigned based on observations of behavioral
signs of ethanol withdrawal as described above (Table 2.2; Morris et al., 2010;
Penland et al., 2001). Mann-Whitney test revealed no significant difference
between treatment groups for mean or peak withdrawal scores (Table 2.5). The
mean withdrawal (WD) score (i.e. mean WD) across the entire 17-hour period of
monitored WD corresponded approximately with hyperactivity on the behavioral
scale (0.8 ± 0.1). Additionally, the mean of the peak WD score achieved (peak
WD) across the entire monitored WD period corresponded approximately with
head tremor (3.1 ± 0.3).
2.3.3 Effect of additional doses of ethanol on reactive proliferation
Immunohistochemistry was used to label BrdU positive (+) cells. Figure
2.2 shows BrdU+ cells in clusters lining the SGZ for each treatment group. BrdU+
cells were profile counted and then analyzed by one-way ANOVA, revealing a
significant effect of 4-day ethanol treatment [F(2,19)=23.78; p < 0.0001]. Tukey’s
multiple comparisons test revealed that rats treated with 4-days of ethanol +
additional doses of control diet (E+C) or 4-days of ethanol + additional doses of
ethanol diet (E+E) had increased BrdU+ cell counts (p < 0.05) compared to 4days of control diet + additional doses of control diet (C+C). However, there was
no significant difference between the two ethanol treatment groups (Figure 2.2).
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Table 2.5 - Mean and peak withdrawal (WD) scores separated by treatment
Treatment groups
Ethanol + Control
Ethanol + Ethanol

Mean WD
0.6 ± 0.2
0.8 ± 0.2

Peak WD
2.8 ± 0.6
3.4 ± 0.2

n
6
8

Table 2.5 - There were no statistical differences between treatment groups for
mean WD or peak WD.
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Figure 2.2 - Representative images and BrdU+ cell counts

Figure 2.2 - Representative photomicrographs of BrdU+ cells seven days postbinge ethanol exposure. As expected, BrdU+ cells were located in clusters
throughout the SGZ. Ethanol administered during reactive proliferation does not
significantly decrease BrdU+ cell counts. Tukey’s multiple comparison test
revealed an increase between ethanol treated groups (E+C and E+E) and
controls (C+C), but no difference between the two ethanol groups. *p < 0.05
n = 6-8; scale bar = 100 µm; insets = 20 µm; GCL = granule cell layer.
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These results indicated that the two additional doses of 5 g/kg ethanol
administered during reactive proliferation did not reduce BrdU+ cell counts at T7
(seven days post-binge).
2.4 DISCUSSION
Decreases in hippocampal cell proliferation are seen during alcohol
intoxication across several animal models (Anderson et al., 2012; Jang et al.,
2002; Nixon and Crews, 2002; Taffe et al., 2010; Tesone-Coelho et al., 2013).
Indeed, a single high dose of ethanol significantly decreased proliferation in the
SGZ of the hippocampal dentate gyrus of ethanol-naïve rats (Nixon and Crews,
2002). Additionally, alcohol has been shown to dose dependently reduce cell
proliferation in adolescent rats (Crews et al., 2006b). However, Nixon and Crews
(2004) revealed that seven days after a 4-day binge model of an AUD there was
a reactive increase in cell proliferation in the SGZ and this effect was replicated
in the present study. The current experiment was designed to test the hypothesis
that two doses of 5 g/kg ethanol, given six to seven days following alcohol
exposure, would decrease alcohol-induced reactive proliferation. Surprisingly,
alcohol-withdrawal induced reactive proliferation in the dentate gyrus at T7 was
robust and resistant to inhibition by ethanol. However, ethanol did slightly
decrease BrdU+ cell counts (18% decrease) in animals that received additional
doses of ethanol; however, this decrease was not significant. Since additional
doses of ethanol did not decrease BrdU+ cell counts, there was no need to test
for additional proliferation markers (i.e. Ki67).
Binge-exposed, ethanol animals show a large increase in NPC
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proliferation compared to controls and therefore decreasing reactive proliferation
could require lengthier or earlier ethanol administration (Hayes et al., in
preparation). A recent study administered a second 4-day binge ethanol
exposure beginning seven days post-binge (a measure that would most likely
decrease reactive proliferation). However this study resulted in cell counts with a
wide variability following the second binge (Maynard and Leasure, 2013).
Therefore, alcohol is likely not the best choice for decreasing alcohol-induced
reactive proliferation. Timing of drug administration should also be considered.
Alcohol-induced reactive proliferation is reported at seven days after binge
alcohol exposure with 80% of surviving cells becoming neurons 28 days later
(Nixon and Crews, 2004), i.e. they express the mature neuronal marker NeuN
(Mullen et al., 1992). However, it is not known if this increase in reactive
proliferation begins prior to T7 (seven days post-binge). But since reactive
proliferation/neurogenesis occurs over multiple days following traumatic brain
injury, seizure, and transient global ischemia in rodents it is possible that alcoholinduced reactive neurogenesis could follow a similar multi-day proliferation
increase (Dash et al., 2001; Liu et al., 1998; Parent et al., 1997). If alcoholinduced reactive proliferation also had multiple days when proliferation was
increased then the drug chosen to decrease proliferation should be administered
ideally across multiple days when the increase in proliferation is seen. For
example, if there was an increase five days after binge alcohol exposure then
(anti-proliferative) drug administration could begin four days after alcohol
exposure and last through six days post-binge (since animals are killed only
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hours into T7). In this way, one could prevent proliferation across the period
when cell proliferation was greatly increased. Therefore, the timeline of reactive
proliferation needs to be investigated.
Alcohol is a pharmacologically promiscuous drug that that affects virtually
every bodily organ system and brain neurotransmitter system (reviewed in Geil et
al., 2014). Initially it was thought that alcohol would be a relevant way to
decrease proliferation since individuals with alcohol abuse problems tend to
repeatedly undergo alcohol binges (Hunt, 1993; McMahon et al., 1991).
However, this process of inhibiting reactive neurogenesis was not necessarily
meant to mimic human behavior. The goal of this experiment was to prevent
reactive proliferation from occurring and unfortunately, alcohol may not be the
best choice since it is not a selective inhibitor of proliferation/neurogenesis.
Temozolomide (TMZ) on the other hand is a selective anti-proliferative drug and
will be used in future experiments. In addition to addressing issue of timing of
drug administration, future chapters will discuss TMZ, a drug that can specifically
target rapidly proliferating cells, such as those undergoing alcohol-induced
reactive proliferation.

Copyright © Chelsea Rhea Geil Nickell 2016
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CHAPTER 3: DETERMINE TIMELINE OF REACTIVE NEUROGENESIS
3.1 INTRODUCTION
Previous research has shown that seven days after binge alcohol
exposure (T7) there is a reactive increase in neurogenesis (reactive
neurogenesis), which may contribute to neuronal regeneration following alcoholinduced hippocampal damage (Nixon and Crews, 2004). However, a more indepth time course for reactive neurogenesis, including pinpointing when it
begins, has not been determined. Classically, reactive neurogenesis has been
seen following brain insults including stroke, traumatic brain injury (TBI), and
seizure (Dash et al., 2001; Parent et al., 1997). Rodent models of TBI and stroke
have been shown to produce increases in neurogenesis (NPC proliferation),
three to seven days post-injury (Dash et al., 2001; Jin et al., 2001). It is likely that
binge alcohol consumption produces a similarly timed reactive increase in
neurogenesis (Nixon and Crews, 2004). Although reactive proliferation following
a 4-day binge model of an AUD was assessed in previous experiments at several
time points (e.g. 0, 2, 4, 7, 10, 14, 28, and 35 days post-binge), the days
immediately prior to the increase in proliferation seen 7 days post-binge (i.e. T5
and T6) had not been previously investigated (Nixon and Crews, 2004; Nixon et
al., 2008). Furthermore, previous experimental time points (listed above) counted
cells across the entire GCL (not just the SGZ) which contributed to high variability
in cell counts. Therefore, the present experiments only counted BrdU+ cells in
the SGZ in effort to more accurately assess hippocampal cell counts at previous
quantified time points (T4 and T7) as well as at new time points (T5 and T6).
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Perhaps one reason why the previous attempt to decrease reactive neurogenesis
was unsuccessful (Chapter 2) was due to incomplete information about the time
course of reactive proliferation four to seven days following binge alcohol
exposure. Essentially, reactive proliferation may begin earlier than was
previously suggested. Additionally, here we investigated a time course for
neurogenic differentiation factor 1 (NeuroD) expression following binge alcohol
exposure. This was done so future experiments could confirm neurogenesis with
NeuroD+ cell counts. NeuroD is one of the earliest markers that a cell has
adopted a neuronal fate and represents an excellent neurogenesis marker (von
Bohlen und Halbach, 2011).
3.2 METHODS
3.2.1 Binge model of an alcohol use disorder
Eighty-three male Sprague-Dawley rats (Charles River Laboratory;
approximately PND 70), each weighing 275-300 grams on arrival, were used for
studies performed with three cohorts. There were two studies in this chapter: one
examined the time course of proliferation and the other investigated
neurogenesis (Table 3.1, Figure 3.1). The time course study included 52 rats, 32
received ethanol diet and 20 received control diet; however, not all rats took-up
BrdU (Eisch et al., 2000). A total of 21 rats were removed and excluded from the
analyses due to failure to take up BrdU: four ethanol rats from the T4 group, two
ethanol rats from the T5 group, two ethanol rats from the T6 group, four ethanol
rats from the T7 group, and nine rats from the control groups. The neurogenesis
study included 31 rats, 17 received ethanol diet and 14 received control diet.
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Table 3.1 - Time course and neurogenesis study: experimental design
Group
T4
T5
T6
T7
T7
T14

Study
Ethanol Control
Time course
4
2
Time course
6
2
Time course
6
3
Time course
4
4
Neurogenesis
8
6
Neurogenesis
9
8

Table 3.1 - Animal numbers separated by diet and study.
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Figure 3.1 - Experimental timeline for proliferation study

Figure 3.1 - All animals underwent a 4-day binge model of an AUD, were injected
with BrdU four to seven days after the binge and sacrificed two hours later.
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All rats in the neurogenesis study were included in the analyses because
NeuroD, an endogenous cellular marker was quantified (no BrdU injections were
needed and therefore no animals were excluded due to their inability to take up
BrdU).
Upon arrival, rats were double housed and allowed to acclimate to the
University of Kentucky AAALAC-accredited vivarium for five days before
experimental procedures began. Animals were kept on a 12-hour light/dark cycle
with ad libitum access to food and water except when noted. All rats were
handled for three days during the acclimation period. All experimental procedures
were completed in accordance with the University of Kentucky Institutional
Animal Care and Use Committee and followed the Guidelines for the Care and
Use of Laboratory Animals (NRC, 1996). On the sixth day in the animal vivarium,
a 4-day binge model of an AUD was initiated (Majchrowicz, 1975; Morris et al.,
2010a).
Animals were randomly divided into two groups with statistically similar
weights, their food was removed and they were administered either 25% (w/v)
ethanol in Vanilla Ensure Plus® (Abbott Laboratories, Columbus, OH) or an
isocaloric control diet (calorically equivalent quantities of dextrose) in Vanilla
Ensure Plus®. Ethanol or control diet was administered every eight hours for four
consecutive days. Ethanol animals received a 5 g/kg ethanol dose initially and
the following doses were titrated based on the animal’s behavioral intoxication
score as described in Chapter 2 (Majchrowicz, 1975; Morris et al., 2010a). All
animals receiving ethanol were scored individually for behavioral intoxication and
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the appropriate dose of ethanol was calculated and administered. After all
ethanol animals had been dosed, the average volume of diet administered to the
ethanol animals was calculated and that volume of control diet was given to all
control animals (Knapp and Crews, 1999). All animals were weighed daily during
alcohol administration to ensure accurate dosing and to monitor animal health.
All ethanol animals underwent monitored withdrawal for 17 hours
beginning 10 hours after the last dose of ethanol (previously described in section
2.2.1). Rats were observed for 30 minutes of every hour for 17 hours (previously
described in Table 2.2). Data are presented as mean withdrawal ± standard error
of the mean and peak withdrawal ± standard error of the mean.
3.2.2 Blood ethanol concentration
Ninety minutes following the seventh dose of ethanol, tail bloods were
collected to determine BEC (as described in section 2.2.2). Briefly, blood
samples were centrifuged at 1,800 x g for five minutes and stored at -20º C until
processing. BECs were determined by an AM1 Alcohol Analyzer (Analox,
Lunenberg, MA) in triplicate with frequent calibration to a 300 mg/dl ethanol
standard. Data are presented as BEC (mg/dl) ± standard error of the mean.
3.2.3 Tissue preparation
Rats in the proliferation time course group were injected with BrdU (300
mg/kg, Roche, Mannheim, Germany) in 0.9% saline 4, 5, 6, or 7 days following
the 4-day binge. Rats in the neurogenesis groups did not receive BrdU injections
and were sacrificed 7 or 14 days following the 4-day binge. Two hours after BrdU
injections (or at a similar time when BrdU injections were not given) rats were
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overdosed with sodium pentobarbital (Fatal-Plus®) and transcardially perfused
using 0.1 M PBS followed by 4% PFA. Brains were removed and post-fixed for
24 hours in 4% PFA. Brains were then cut into 40 µm thick coronal sections and
collected in a 1:12 series on a vibrating microtome (Leica VT1000S; Wetzlar,
Germany). Sections were stored in a cryoprotectant at -20º C until use. Brains
were coded to ensure the experimenter was blind to the treatment conditions.
3.2.4 Immunohistochemistry
3.2.4.1 Bromodeoxyuridine
Immunohistochemistry was performed on every sixth section (free floating
tissue) as previously described in section 2.2.5 (McClain et al., 2011; Nixon and
Crews, 2002). Briefly, sections were rinsed in TBS between each incubation
step. Sections were incubated in 0.6% hydrogen peroxide, followed by antigen
retrieval and DNA denaturing steps using standard sodium citrate (SSC) and
formamide. Tissue was rinsed in SSC, incubated in 2N HCl, and then neutralized
in boric acid (pH 8.5). Tissue was incubated in blocking buffer with normal horse
serum (Vector Laboratories; Burlingame, CA), rinsed in reaction buffer, incubated
in DNAse, rinsed in blocking buffer (3% normal horse serum/0.1% Triton X100/TBS), and incubated in primary antibody overnight (1:5000 mouse anti-BrdU
MAB3424, Millipore). Sections were rinsed in blocking buffer, followed by
incubations in secondary antibody (1:200, biotinylated anti-mouse IgG made in
horse), avidin-biotin-complex (ABC Elite Kit, Vector Laboratories, Burlingame,
CA), and nickel-enhanced 3,3’-Diaminobenzidine (DAB; Polysciences,
Warrington, PA) for visualization. All sections were mounted onto slides and
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allowed to dry overnight. Sections were then counterstained lightly with Cresyl
Violet (as described in Chapter 2). Then, glass coverslips and Cytoseal®
(Richard Allen Scientific, Kalamazoo, MI) were used to seal the slides. Slides
were coded to ensure experimenter was blind to the treatment conditions.
3.2.4.2 Neurogenic differentiation factor 1
NeuroD is a basic helix-loop-helix transcription factor that is essential for
proper pancreatic and neuronal development. Interestingly, NeuroD knockout
mice have dramatically reduced insulin levels and do not survive past postnatal
day five due to hyperglycemia (Chae et al., 2004; Naya et al., 1997). Since
knock-out mice die shortly after birth, researchers used a transgenic technique to
specifically rescue the pancreatic NeuroD phenotype while leaving the neuronal
NeuroD phenotype knocked-out (Chae et al., 2004; Miyata et al., 1999).
Amazingly, these mice survived over a year but completely lacked a hippocampal
dentate gyrus (Miyata et al., 1999). As such, NeuroD is very strongly linked to
neurogenesis. Additionally, NeuroD expression is considered one of the earliest
indicators that a NPC has adopted a neuronal fate (i.e. will become a neuron).
NeuroD has an expression profile very similar to the microtubule-associated
protein doublecortin (DCX), the former ‘gold standard’ marker of cells undergoing
neurogenesis (Brown et al., 2003; Nicola et al., 2015; Pataskar et al., 2016).
NeuroD offers multiple advantages over DCX: the first, NeuroD is more specific
than DCX. Recent studies show that DCX is not specific to neurons (Diaz et al.,
2013). Second, NeuroD is a transcription factor and therefore results in a nuclear
stain that is easier to quantify with profile cell counts (Gao et al., 2009; Lee et al.,
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1995). DCX stains the entire cell body and processes which can require analysis
with densitometry, a non-preferred method of quantification that counts pixels of
color rather than the actual number of cells. Although NeuroD and DCX have
similar expression profiles (von Bohlen und Halbach, 2011), NeuroD has not
been investigated following a 4-day binge model of an AUD. To that end, we
investigated a time course for NeuroD expression following binge alcohol
exposure so future experiments could confirm neurogenesis with NeuroD+ cell
counts instead of having to use DCX.
Immunohistochemistry was performed on every 12th section (free floating
tissue). Tissue was rinsed in TBS between incubation steps. Tissue was
incubated in 0.6% hydrogen peroxide for 30 minutes, Antigen Retrieval Citra
Solution (BioGenex, Fremont, CA) for 1 hour at 65º C, and blocking buffer [3%
normal rabbit serum (Vector Laboratories, Burlingame, CA), 0.1% triton-X, and
TBS] for 30 minutes. Tissue was incubated in primary antibody (1:1000 goat antiNeuroD SC-1084, Santa Cruz Biotechnologies, Dallas, TX) in blocking buffer for
~42 hours at 4º C. Tissue was rinsed in blocking buffer, incubated in secondary
antibody (1:200, biotinylated anti-goat IgG made in rabbit) for 1 hour, avidinbiotin-complex (ABC Elite Kit, Vector Laboratories, Burlingame, CA) for 1 hour,
and nickel-enhanced 3,3’-Diaminobenzidine for 70 seconds (DAB; Polysciences,
Warrington, PA) for visualization. All sections were mounted onto slides and
allowed to dry overnight then coverslipped with Cytoseal® (Richard Allen
Scientific, Kalamazoo, MI). Slides were coded to ensure that the experimenter
was blind to the treatment conditions.
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3.2.5 Quantification
3.2.5.1 Bromodeoxyuridine
BrdU+ cell profiles were counted in the SGZ of the dorsal dentate gyrus
using a 100x objective lens attached to an Olympus BX41 microscope (as
previously described). Briefly, BrdU+ cells were quantified on a single
hemisphere between Bregma -2.28 mm and -5.52 mm as determined by an atlas
(Paxinos and Watson, 2009). For each brain, all sections were inspected and the
side without tears to the SGZ was selected for obtaining cell counts. Data are
presented as average SGZ cells/section ± standard error of the mean.
3.2.5.2 Neurogenic differentiation factor 1
Unbiased stereology utilizing the optical fractionator method (West, 1991)
was used to estimate the number of NeuroD+ cells in the SGZ of the dorsal
hippocampal dentate gyrus (McClain et al., 2011). An Olympus BX51 microscope
coupled to a ProScan II motorized stage, microcator, DP70 digital camera
(Olympus, Center Valley, PA), and a Dell Precision 380 computer with newCAST
Stereology System software was utilized (Visiopharm version 3.6.4.0,
Hoersholm, Denmark). For each hippocampus section, the SGZ or GCL was
traced at 100x magnification and an average section thickness was obtained
from three measurements at different locations at 600x magnification (60x oil
objective, PlanApo N, Olympus). Immunohistochemical tissue processing yielded
a mean section thickness of ~18 µm and consequently, a dissector height of 14
µm with 2 µm guard zones was used. Random sampling was set up using a 20
µm X 20 µm counting frame and an 80 µm x,y step length for NeuroD
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(parameters established with assistance from Dr. Justin McClain). Cells were
counted at 1200x magnification from live images projected onto the computer
screen with the overlaying counting frame. The total number of NeuroD+ cells in
the SGZ and the total number of granule cells in the GCL was estimated using
the following formula (West, 1991):

𝑁𝑁 = ∑ 𝑄𝑄 ×

1

𝑎𝑎𝑎𝑎𝑎𝑎

×

1

𝑡𝑡𝑡𝑡𝑡𝑡

×

1

𝑠𝑠𝑠𝑠𝑠𝑠

Where N is the estimated total number of cells, Q is the number of
immunopositive cell profiles that were counted, asf is the area sampling fraction
(the counting frame: x,y step ratio), tsf is the thickness sampling fraction (height
of dissector: section thickness ratio), and ssf is the section sampling fraction (the
fraction of sections examined). One brain was removed because it was missing
dorsal hippocampus sections. Data are presented as total NeuroD+ cells/SGZ ±
standard error of the mean.
3.2.6 Statistics
All data were analyzed with GraphPad Prism (version 7.0, GraphPad
software, La Jolla, CA). Intoxication data were analyzed by comparing ethanol
groups using a one-way ANOVA (ethanol dose and BEC) and the nonparametric
Kruskal-Wallis test (intoxication and withdrawal scores). Time course data (BrdU)
were designed to be assessed with a one-way ANOVA. Therefore, controls were
first compared via one-way ANOVA and collapsed into a common control group
when not statistically different. Then, time course data was assessed by one-way
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ANOVA followed by Dunnett’s multiple comparisons test. Neurogenesis data (T7
and T14) were assessed using a two-way ANOVA (diet x day) followed by
Bonferroni’s multiple comparisons test. For neurogenesis groups, intoxication
data were analyzed by comparing ethanol groups using a two-tailed student’s ttest (ethanol dose and BEC) and the nonparametric Mann-Whitney test
(intoxication and withdrawal scores). P-values were accepted as significant when
p < 0.05.
3.3 RESULTS
3.3.1 Time course of alcohol-induced reactive proliferation
3.3.1.1 Animal model and withdrawal data for time course study
During the 4-day binge model of an AUD, data were collected to assess
similarities in intoxication between time points and are detailed in Table 3.2.
Increased intoxication can correlate with increased levels of proliferation.
Therefore, intoxication parameters were analyzed to determine if significant
differences were present among the different time points. One-way ANOVA
revealed no significant difference in dose or BEC across the different time points.
The Kruskal-Wallis test showed no significant difference in intoxication or
withdrawal scores across the different time points. Therefore, ethanol animals
had a mean intoxication score of 1.7 ± 0.1 on the 6-point intoxication scale which
is represented behaviorally by ataxia with an elevated abdomen (Majchrowicz,
1975). Intoxication scores resulted in animals receiving a mean of 9.9 ± 0.3
g/kg/d ethanol, and corresponded to a mean BEC of 359 ± 18 mg/dl. These
values are similar to those previously reported (Morris et al., 2010a).
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Table 3.2 - Animal model data: time course study
Days
Intoxication
Dose
post-binge
score
(g/kg/day)
4
1.8 ± 0.1
9.7 ± 0.3
5
1.6 ± 0.1
10.1 ± 0.4
6
1.9 ± 0.1
9.2 ± 0.3
7
1.5 ± 0.4
10.6 ± 1.1

BEC
(mg/dl)
324 ± 5
330 ± 44
412 ± 11
356 ± 42

Mean
WD
0.6 ± 0.1
0.9 ± 0.2
0.7 ± 0.2
0.8 ± 0.1

Peak
WD
3.4 ± 0.2
3.1 ± 0.1
3.4 ± 0.2
3.5 ± 0.2

n
4
6
6
4

Table 3.2 - All time points had statistically similar intoxication scores, daily
ethanol doses, BEC’s, and withdrawal scores. Thus, exposures are equivalent
across the different time points.
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Withdrawal scores were assigned based on observations of behavioral signs of
ethanol withdrawal (Penland et al., 2001). The Kruskal-Wallis test revealed no
significant differences among time points for mean or peak withdrawal scores
(Table 3.2). Here, the mean withdrawal score was 0.8 ± 0.1 which corresponded
to hyperactivity on the behavioral withdrawal scale (Table 2.2). Additionally, the
peak withdrawal score was 3.3 ± 0.1 which corresponded to induced running.
3.3.1.2 Time course of proliferation following binge alcohol exposure
Proliferation was measured using IHC for cells that have incorporated
BrdU during DNA synthesis. BrdU with DAB-IHC was performed on rat brain
tissue obtained either 4, 5, 6, or 7 days post-alcohol exposure. Representative
images illustrate BrdU+ cells along the SGZ in ethanol and control animals for
each time point (Figure 3.2). One-way ANOVA revealed that control BrdU+ cell
counts at each time point were statistically similar [F(3,7)=3.1; p=0.10] and
therefore controls were combined into one common control group. One-way
ANOVA compared BrdU+ cell counts at each time point against controls and
revealed an effect of diet [F(4,26)=29.69; p < 0.0001]. Dunnett’s multiple
comparisons test revealed a significant increase in BrdU+ cell counts in ethanol
groups on T5 (p < 0.005), T6 (p < 0.0005), and T7 (p < 0.0005) when compared
to the combined control group (Figure 3.3).
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Figure 3.2 - Representative images for time course of reactive proliferation

Figure 3.2 - Representative images are shown for each time point for both control
and binge ethanol groups. Only cells that resided within the SGZ were quantified.
Images were taken at 80x magnification, boxed inset images were taken at
1200x magnification. Scale bar = 100 µm; 20 µm inset.
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Figure 3.3 - Time course of alcohol-induced reactive proliferation

Figure 3.3 - Increased alcohol-induced reactive proliferation begins five days
post-binge and continues through 7 days post-binge. *p < 0.005 indicates a
significant increase from control.
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3.3.2 Confirmation of reactive neurogenesis
3.3.2.1 Animal model and withdrawal data
To confirm reactive neurogenesis following a 4-day binge model of an AUD, rats
were sacrificed either 7 (T7) or 14 (T14) days post-binge. These time points were
selected because the increase in proliferation seen at T7 results in an increase in
neurogenesis at T14 (Brown et al., 2003; Nixon and Crews, 2004). Table 3.3
summarizes animal model data from the two different groups of animals given
ethanol (T7 and T14). Student’s t-test’s compared T7 and T14 ethanol groups
and showed no significant difference in daily ethanol dose, but revealed a
significant difference in BEC’s [t(15)=2.55, p=0.022]. Nonparametric data was
analyzed with Mann-Whitney tests and showed no significant difference in
intoxication score, but revealed a significant difference in both mean [U=5,
p=0.001] and peak [U=8, p=0.001] withdrawal scores between T7 and T14
ethanol groups. Although there were differences between T7 and T14 groups in
terms of BEC and withdrawal, all animals had similar intoxication scores and
received similar doses of ethanol.
3.3.2.2 Alcohol-induced reactive neurogenesis seen with NeuroD
To further characterize the time course of reactive neurogenesis following binge
ethanol exposure, NeuroD immunoreactivity was examined at both one and two
week’s post-ethanol administration. As shown in Figure 2.4 A-D, the SGZ of the
hippocampal dentate gyrus displayed ample NeuroD+ labeling in all groups. A
two-way ANOVA (diet x time point) revealed significant main effects of both diet
[F(1,27)=6.48, p<0.05] and time point [F(1,27)=22.31, p<0.001], as well as a
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Table 3.3 - Animal model parameters for the neurogenesis study
Days
Post-binge
7
14

Intox.
score
1.8 ± 0.1
1.9 ± 0.1

Dose
(g/kg/day)
9.8 ± 0.4
9.3 ± 0.3

BEC
(mg/dl)
307 ± 25*
377 ± 13

Mean
WD
1.0 ± 0.1*
1.8 ± 0.2

Peak
WD
3.0 ± 0.0*
3.6 ± 0.1

n
8
9

Table 3.3 - Intoxication scores and daily ethanol doses were statistically similar
between T7 and T14 time points; however, there were differences between
BEC’s and withdrawal (WD) scores between T7 and T14. *=p < 0.05
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Figure 3.4 - Representative images and NeuroD+ cell counts for T7 and T14

Figure 3.4 - The total number of NeuroD+ cells are increased following 14, but
not 7, days of abstinence in ethanol-treated rats. Representative images of the
hippocampal dentate gyrus taken at 100x are shown for control (A, C) and
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Figure 3.4 (continued)
ethanol-exposed animals (B, D) at 7 days (A, B) and 14 days (C, D) post-ethanol
exposure. Insets for all images were taken at 600x. The number of NeuroD+ cells
in the SGZ of the hippocampal dentate gyrus was determined using unbiased
stereology as shown in panel E. GCL, granule cell layer; scale bar = 100 µm;
inset scale bar = 20 µm; *p < 0.05 = a significant increase in NeuroD+ cells in the
ethanol group compared to controls at T14.
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significant interaction [F(1,27)=17.68, p<0.001]. Bonferroni multiple comparisons
test revealed a significant increase in the total number of NeuroD+ cells in the
SGZ of ethanol rats compared to controls at the 14-day time point (p<0.001), but
not at the 7-day time point. Because NeuroD is a marker of cells committed to a
neuronal fate (Gao et al., 2009), the increase in NeuroD+ cells at T14 may reflect
an increase in the number of new neurons originating from reactive neurogenesis
(including the cells undergoing reactive proliferation on day 7 post-binge).
3.4 DISCUSSION
Here we show, for the first time, when the increase in alcohol-induced
reactive proliferation is first detectable. This finding indicates that binge alcohol
exposure resulted in an increase in BrdU+ cell counts 5-7 days post-binge (T5,
T6, T7). BrdU was used as a marker of proliferating cells and, as such, an
increase in BrdU+ cells represents an increase in the number of proliferating
cells. Because this proliferation occurred following binge alcohol exposure, it is
further classified as reactive proliferation. BrdU+ cell counts revealed no
difference between ethanol and control rats 4 days (T4) after the end of binge
alcohol exposure but showed increased proliferation 5, 6, and 7 days after the
end of binge alcohol exposure. Although previous reports investigated
proliferation at multiple time points following binge alcohol exposure, proliferation
had not been examined 5 and 6 days post-binge (Nixon and Crews, 2004; Nixon
et al., 2008). Here, a more extensive time course was necessary to ensure a
thorough understanding of the timing of alcohol-induced reactive proliferation; a
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necessary step to establish a novel protocol to decrease alcohol-induced reactive
proliferation.
The increase in cell proliferation (BrdU+ cell counts) spanning multiple
days (T5-T7) is consistent with that reported in animal models of ischemia and
seizure (other models that result in neurodegeneration) which show a reactive
increase in cell proliferation one week later (Liu et al., 1998; Parent et al., 1997;
Smith et al., 2005). Research involving the 4-day binge model used here has
shown increased proliferation at two time points post-binge (keep in mind BrdU is
not specific to neurons – it labels all cells replicating at the time of injection). We
have already thoroughly discussed the increase in proliferation occurring on T7
that results in ~80% mature neurons 28 days later (Nixon and Crews, 2004). In
addition to T7 neurogenesis, there is also an increase in BrdU+ cells
(proliferation) two days post-binge (T2). T2 studies used a BrdU injection on T2
followed by a 28 day waiting period (to allow cells to mature) and then triple-label
IHC revealed that cells proliferating on T2 (assuming survival) primarily matured
into microglia, not neurons (Nixon et al., 2008). There are no studies that
birthdate proliferating cells at T5 (with BrdU) and examine them 28 days later,
when they are considered mature neurons. As such, we cannot definitively say
that T5 proliferation resulted in an increase in mature neurons; for that additional
studies are needed. It is possible that T5 proliferation may generate microglia
instead of neurons however, that is unlikely for a couple of reasons. Recently, we
have used quadruple-label IHC and revealed that, at T5, ethanol rats show a 2fold increase in the number of cells expressing an early neuronal marker
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compared to controls (Hayes et al., in preparation). This recent study by Hayes et
al. revealed some important points: one, it confirmed that there was an increase
in proliferation with Ki67 at T5 in ethanol rats, and two, it was able to show that
the increased proliferation seen at T5 was generating cells expressing neuronal
markers (NeuroD). This means that the increased proliferation seen at T5 is
neuronal. Furthermore, previous studies have shown that proliferation increases
at T2 (yielding microglia; BrdU+/Iba1+/NeuN- cells), which normalizes by T4 and
is followed by a separate increase in proliferation at T7 which yields neurons
(Nixon and Crews, 2004; Nixon et al., 2008). The present study did not observe a
difference in the number of SGZ BrdU+ cells between ethanol and controls at the
T4 time point which lends support to separation between the two proliferation
increases (seen at T2 and T7). Additionally, the T4 time point was investigated in
Nixon and Crews (2004) and showed similar results to the present study in that
there was no significant difference between ethanol and control groups at T4.
Although, the dentate gyrus regions that were quantified were not identical
between Nixon and Crews (2004) and the present study. The entire GCL was
counted in the 2004 study (while only the SGZ was quantified in the present
study) which resulted in increased variability compared to the present study.
Additional clues to indicate the cell type come from examining the tissue sections
at the various time points. For example, T2 hippocampal sections show a
random, yet even, distribution of BrdU+ cells across the dentate gyrus including
numerous cells in the hilus region (Nixon et al., 2008). That same, hilar, even,
random pattern (and hilar region staining) of BrdU+ cell expression is seen in the
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present experiments but only in the T4 ethanol brain (Figure 3.2). In summary, it
is likely that there is some separation between the two events (T2 and T7) and
that the proliferation occurring at T5-7 likely results in neurogenesis. However, an
additional experiment involving triple-label IHC would be needed to determine if
the cells proliferating at T5 and T6 go on to primarily become mature neurons.
The present studies can only conclusively state that there is an increase in
proliferation from T5-T7 and that there is an increase in neurogenesis at T14 in
ethanol animals compared to controls.
Original studies investigating the time course of reactive neurogenesis
following 4-day binge ethanol exposure showed that an increase in cell
proliferation at T7 is followed by an increase in doublecortin (DCX)immunoreactivity one week later (on T14) suggesting that the newly born
neurons are capable of differentiation into immature neurons (Nixon and Crews,
2004). However, recent research reports indicate that DCX should be cautiously
interpreted because DCX+ cells are not neuron-specific; DCX+ cells can coexpress the oligodendrocyte precursor marker, Olig2 (Diaz et al., 2013).
Therefore, we utilized NeuroD, a transcription factor expressed by progenitor
cells committed to a neuronal fate and known to overlap with DCX expression to
confirm the original findings of reactive neurogenesis (Lee et al., 1995; Steiner et
al., 2006). As anticipated, we showed a significant increase in NeuroD+ cells at
T14, but not at T7, thereby mirroring the DCX timeline originally reported by
Nixon and Crews in 2004.
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Differences in the animal model data could represent a study limitation.
Analysis of animal model data revealed an increase in BEC’s, and mean and
peak withdrawal in T14 animals when compared to T7 animals. An increase in
intoxication level could potentially result in a larger increase in reactive
neurogenesis. However, BEC is only examining blood alcohol levels at a single
time point and as such is not necessarily indicative of intoxication throughout the
entire 4-day binge. A more accurate representation of intoxication throughout the
duration of the binge comes from the behavioral intoxication scores which are
taken every eight hours for the entire 4-day binge and these were not
significantly different between T7 & T14. The mean dose of alcohol given was
also not significantly different between time points. This information coupled with
similar studies showing increases in DCX, a marker with a similar expression
pattern to NeuroD, indicates that the increased NeuroD expression seen in
ethanol animals at T14 is likely due to increased neurogenesis and not a result of
differences in animal model data (McClain et al., 2014). However, since two
measures of intoxication suggest that the model, overall, may be different
between groups, model differences cannot be ruled out.
Overall this research represents a significant contribution to the reactive
neurogenesis field. Previously, alcohol-induced increases in neuronal
proliferation were only reported on T7 (McClain et al., 2014; Nixon and Crews,
2004). Here we show that this increased proliferation starts earlier than realized,
occurs over multiple days, and is followed by an increase in reactive
neurogenesis at T14. The research reported in this study indicated that (for future
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studies detailed in the following chapter) inhibition of reactive proliferation must
start beginning on T4, just prior to the increase seen at T5-7, and administration
should continue through at least T6. This information will assist in establishing a
method to reduce reactive proliferation/neurogenesis, thereby allowing us to
investigate reactive neurogenesis’s contribution to neuronal recovery following a
binge model of an AUD.

Copyright © Chelsea Rhea Geil Nickell 2016
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CHAPTER 4: INHIBITION OF REACTIVE PROLIFERATION AND
NEUROGENESIS USING TEMOZOLOMIDE
4.1 INTRODUCTION
Excessive alcohol consumption contributes to widespread
neurodegeneration (discussed in detail in section 1.2.3). Alcohol can damage
both white matter tracts comprised of glial cells (microglia, astrocytes, and
oligodendrocytes) and grey matter tracts composed of neurons (reviewed in
Alfonso-Loeches and Guerri, 2011). In humans, cognitive deficits are associated
with alcohol-induced cellular loss (Beresford et al., 2006; Parada et al., 2011;
Pfefferbaum et al., 1992). Animal models of alcohol use disorders also show
deficits in learning and memory (Cippitelli et al., 2010; Kuzmin et al., 2012;
Obernier et al., 2002b). A 4-day binge model of an AUD resulted in a learning
deficit in alcohol exposed rats (compared to controls) one week post-binge (see
Appendix, Supplemental Figure 1). However, with cessation of alcohol intake
comes recovery and studies show that a certain amount of brain regeneration (in
terms of grey and white matter volume) can occur (van Eijk et al., 2013; O’Neill et
al., 2001; Pfefferbaum et al., 1995).
Adult neurogenesis may contribute to neuronal recovery. When high
concentrations of alcohol are administered (like during binge exposure), adult
neurogenesis is substantially reduced (Nixon and Crews, 2002) and then
increases in proliferation are seen 5-7 days post-binge (Hayes et al., in
preparation; Nixon and Crews, 2004). This increase is thought to be the brain’s
way of compensating for the cells it was unable to produce during intoxication
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(Crews and Nixon, 2009; Crews et al., 2006a). Therefore, the brain’s reaction to
alcohol-induced reduced neurogenesis is to temporarily increase neurogenesis to
make-up for lost time (or, lost neurons in this case). The process has been
termed alcohol-induced reactive neurogenesis and its function is unknown.
An important question that has not been address is whether reactive
neurogenesis is beneficial for recovery from AUDs. Since the hippocampus is
involved in learning and memory, studies have investigated alcohol’s effects on
hippocampal-dependent tasks. In fact, research in the Nixon lab has shown that
adult rats tested in the MWM 7-10 days after binge alcohol treatment swam
longer distances before locating the hidden platform, which is indicative of a
learning deficit (see Appendix, Supplementary Figure 1). However, these deficits
normalized by 3 weeks post-binge (Obernier et al., 2002b). Since hippocampaldependent learning and memory returns to normal after reactive neurogenesis, it
is possible that reactive neurogenesis may contribute to the functional recovery
of the hippocampal dentate gyrus. Although the previous statement is purely
correlative evidence, additional experiments must be done to test causation.
To assess the contribution that reactive neurogenesis makes to regaining
hippocampal function we administered Temozolomide (TMZ), a DNA alkylating
agent that can penetrate the blood brain barrier and kill rapidly proliferating cells
(Chowdhury et al., 1999; Omar and Mason, 2009). Since Type 2 NPCs are
rapidly proliferating cells produced during neurogenesis, it is possible that TMZ
could reduce alcohol-induced reactive neurogenesis. However, the effect of TMZ
on alcohol-induced reactive neurogenesis has never been investigated.
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Furthermore, there is no way to know which cells are reactive or which cells are
contributing to constitutive neurogenesis since there is not a way to tease apart
these populations. Thus, there is no way to target only the reactive population
since we cannot differentiate this population from the cells undergoing normal
neurogenesis. Therefore, the best approach was to reduce proliferation in
general with TMZ and then test rats in a hippocampal dependent task (MWM).
Using this approach it was possible to investigate the role of reactive
neurogenesis in recovery of hippocampal function (learning and memory). If
endogenous reactive neurogenesis is involved in hippocampal recovery then it
would represent a novel target for pharmaceutical intervention.
The purpose of this study was to develop an approach to reduce alcoholinduced reactive neurogenesis to basal neurogenesis levels seen in control
animals. First, an appropriate dose of TMZ was determined. Second, the
appropriate dose of TMZ was tested to ensure that it could decrease proliferation
and the associated neurogenesis; care was taken to ensure that TMZ did not
simply delay reactive proliferation. Third, we assessed how inhibiting reactive
neurogenesis (with TMZ) would affect hippocampal learning and memory. The
main purpose of these experiments was to address this third point.
Determining a dose of TMZ that was able to decrease reactive
proliferation was the first goal. Previous studies used 25-50 mg/kg TMZ to
decrease basal neurogenesis by cyclical administration, three days on/four days
off for multiple weeks (Garthe et al., 2009; Niibori et al., 2012; Nokia et al., 2012).
Since alcohol-induced reactive proliferation occurs over a short period (T5-T7),
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the present study only allowed for a single three-day cycle to effectively target
alcohol-induced reactive proliferation (Figure 3.1). Also, data from Chapter 3
indicated that the optimal time for TMZ administration would be four to seven
days following alcohol administration. Although there is no increase in
proliferation at T4, there is an increase at T5, and we hypothesized that to
effectively decrease proliferation at T5 the drug needs to be administered prior to
the increase. A dose response curve determined the appropriate concentration of
TMZ to administer and the following experiments used that regimen that reduce
reactive NPC proliferation to control levels.
Once a dose of TMZ that effectively decreased reactive proliferation was
determined, we confirmed the results by examining a marker of neurogenesis.
Because the proliferation marker BrdU is not neuron-specific, it was necessary to
use a neurogenesis-specific marker to confirm neurogenesis (NeuroD). Previous
studies revealed that reactive proliferation is seen at T7 and reactive
neurogenesis is seen at T14 (Nixon and Crews, 2002; 2004). Neurogenesis was
investigated 14 days after the last dose of ethanol ensure that reactive
proliferation was not delayed.
The ultimate goal of these experiments was to determine if alcoholinduced reactive neurogenesis contributed to recovering the deficit seen 7-10
days post-binge in the MWM in rats (Supplemental Figure 1). Therefore, after the
normalization of reactive proliferation and neurogenesis were confirmed, a
hippocampal-dependent learning and memory task (MWM) was administered to
assess the potential function of alcohol-induced reactive proliferation.
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4.2 METHODS
4.2.1 Binge model of an alcohol use disorder
Three separate experiments used a total of 114 male Sprague-Dawley
rats weighing 275-300 grams on arrival (Table 4.1; Charles River Laboratory;
PND 70). One rat (a T14 saline + ethanol rat) was excluded from analysis
because of failure to incorporate BrdU. Rats were double housed and allowed to
acclimate to the University of Kentucky AAALAC-accredited vivarium for five
days before experimental procedures began. Rats were kept on a 12-hour
light/dark cycle with ad libitum access to food and water except when noted. All
rats were handled for three days before the experiments began. All experimental
procedures were completed in accordance with the University of Kentucky
Institutional Animal Care and Use Committee and followed the Guidelines for the
Care and Use of Laboratory Animals (NRC, 1996).
For each of the three experiments detailed below, the rats were divided into two
groups with statistically similar weights and administered either 25% (w/v)
ethanol in Vanilla Ensure Plus® (Abbott Laboratories, Columbus, OH) or an
isocaloric control diet (calorically equivalent quantities of dextrose) in Vanilla
Ensure Plus®. Ethanol or control diet was administered every eight hours for four
consecutive days. Ethanol animals received 5 g/kg ethanol diet initially and the
subsequent doses were titrated based on the animal’s behavioral intoxication
score according to the scale in Chapter 2 (Table 2.1; Majchrowicz, 1975; Morris
et al., 2010).
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Table 4.1 - Temozolomide studies: experimental design
Time point
T7
T7
T7

TMZ dose
Saline
25 TMZ
50 TMZ

T14
T14

Saline
50 TMZ

T35
T35

Saline
50 TMZ

Study
4.3.1
4.3.1
4.3.1
Total
4.3.2
4.3.2
Total
4.3.3
4.3.3
Total

Ethanol
8
9
8
43
7
8
31
9
11
40

Control
6
6
6
8
8
10
10

Table 4.1 - Animal numbers separated by time point, TMZ dose (mg/kg/day),
study, and diet.
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All ethanol animals underwent monitored withdrawal for 17 hours
beginning 10 hours after the last dose of ethanol (previously described in
Chapter 2). Rats were observed for 30 minutes of every hour for 17 hours and
withdrawal behavioral features (listed in Table 2.2) were recorded (Majchrowicz,
1975; Morris et al., 2010a; Penland et al., 2001). Results for each experimental
time point (T7, T14, and T38) were analyzed separately because each is
considered a separate experiment. Data are presented as mean withdrawal ±
standard error of the mean and peak withdrawal ± standard error of the mean.
4.2.1.1 Blood ethanol concentration
Ninety minutes following the seventh dose of ethanol, tail bloods were
collected to determine BEC (previously described in Chapter 2). Blood samples
were centrifuged at 1,800 x g for five minutes to separate blood plasma from
blood cells and then stored at -20º C until processing. Supernatant blood serum
was processed in triplicate using an AM1 Alcohol Analyzer (Analox, London, UK).
Data are presented as BEC (mg/dl) ± standard error of the mean.
4.2.2 Temozolomide
Following the 4-day binge model of an AUD, rats were administered TMZ,
a DNA alkylating agent used to decrease cellular proliferation (Garthe et al.,
2009, 2016; Nokia et al., 2012). Animals were weighed daily just prior to TMZ
administration and TMZ (Cayman Chemicals, Ann Arbor, MI) was made fresh
prior to each injection (5 mg/ml in 0.9% normal saline). TMZ was sonicated for 30
minutes at 35º C in a water bath and then the solution was then transferred to a
cell culture hood and filter sterilized. A vehicle solution of 0.9% normal saline was
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injected as a control into all rats not receiving a TMZ injection. All rats in these
experiments (listed here and below) received the same number of i.p.
(intraperitoneal) injections at approximately the same times to ensure similarity
between groups.
4.2.2.1 Temozolomide optimization study: T7
To establish a dose of TMZ capable of decreasing alcohol-induced
reactive proliferation, 43 rats (Table 4.1) were given one injection every 12 hours
for 3.5 days starting 3.5 days after the last dose of ethanol (Figure 4.1). Rats
received either (A) one saline injection every 12 hours, (B) alternating injections
of 25 mg/kg TMZ and saline (to balance the number of injections), or (C) one 25
mg/kg TMZ injection given every 12 hours – resulting in a total daily dose of 50
mg/kg/d TMZ. Animals were injected with BrdU (300 mg/kg, Roche, Mannheim,
Germany) in 0.9% saline seven days following binge alcohol exposure (T7, ~168
hours after their last dose of ethanol). Two hours later rats were sacrificed by
pentobarbital overdose (Fatal Plus®) followed by intracardial perfusion and brain
extraction (as previously described in Chapter 2). Animals were sacrificed on T7
to determine if TMZ was able to decrease the reactive increase in proliferation on
T7. TMZ was not given on T7 due to timing and consistency issues. Animals are
injected with BrdU ~168 hours (7 days) after their last alcohol exposure and
sacrificed two hours later. It is not known if BrdU and TMZ interact and therefore
administering these drugs within a couple hours of one another is not ideal (i.e.
giving TMZ at 7 AM and then giving BrdU at 9 AM).
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Figure 4.1 - Experimental design diagram for TMZ studies
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Figure 4.1 - Timeline of Temozolomide (TMZ) administration. Rats underwent four days of binge alcohol exposure and
were then given TMZ (or saline) injections every 12 hours for 3.5 days. Rats were then injected with BrdU and sacrificed
(Sac) either seven or 14 days post-binge. T38 rats were sacrificed 38 days post-binge after the MWM.

Also, BrdU’s solubility is such that large volumes must be i.p. injected and closely
timed BrdU and TMZ injections would exceed max injection volumes if animals
were injected with BrdU and TMZ within a couple hours of each other.
Additionally, in order to maintain consistency with previous studies within our
laboratory the rats needed to be sacrificed early on T7 (which begins at 7 AM)
and so it was not ideal to push back the sacrifice time. Therefore, a 7 AM dose of
TMZ was not included so BrdU could be administered instead.
4.2.2.2 Proliferation and neurogenesis study: T14
Based on the success of the dosing regimens listed above the rats in this
experiment (n=32) were given one 25 mg/kg injection every 12 hours, resulting in
a total daily dose of 50 mg/kg/d TMZ (as described immediately above).
Injections began 3.5 days after the last dose of ethanol and continued for 3.5
days (Figure 4.1). Rats were injected with BrdU (300 mg/kg, Roche, Mannheim,
Germany) in 0.9% saline, 14 days following binge alcohol exposure (T14).
Animals were sacrificed two hours later by pentobarbital overdose (Fatal Plus®)
followed by transcardial perfusion and brain extraction (previously described in
Chapter 2). This T14 time point was selected because reactive proliferation
occurring on T7 results in a reactive increase in neurogenesis and can be seen
with an early marker of neurogenesis, one week following the T7 proliferation
increase on T14. Furthermore, the addition of an anti-proliferative drug during
reactive proliferation could simply delay the reactive increase that occurs on T7,
so proliferation was examined one week later.
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4.2.2.3 T38 MWM study: determine the effect of TMZ on MWM behavior
Based on the success of the dosing regimens listed above, rats in this
experiment (n=40) were given one 25 mg/kg injection every 12 hours, resulting in
a total daily dose of 50 mg/kg/d TMZ (as described in section immediately
above). Injections began 3.5 days after the last dose of ethanol and continued for
3.5 days (Figure 4.1). Animals were sacrificed 38 days following binge alcohol
exposure (T38) by pentobarbital overdose (Fatal Plus®) followed by intracardial
perfusion and brain extraction, previously described in Chapter 2. The T38 time
point was selected since reactive neurogenesis occurs 7 days after binge
exposure (Nixon and Crews, 2004) and because Jessberger and Kempermann
(2003) indicated that newborn neurons require 28 days to express mature
neuronal markers (7 days + 28 days + 4 days of MWM = 38 days). Additional
studies show that cells that are a minimum of 28 days old are recruited for use in
the MWM, and young neurons that are six to eight weeks old are more than twice
as likely to be utilized for the MWM task (Kee et al., 2007). T38 animals were not
given BrdU because this experimental time point was focused on behavioral
outcome measures. However, these brains were harvested in the event that
further analysis was needed.
The MWM was used to assess spatial learning and memory following
binge alcohol exposure and TMZ administration. Experiments were conducted
similar to previous studies (Verbois et al., 2003) with equipment in collaboration
with the laboratory of Dr. James Pauly. Briefly, five weeks post-binge alcohol
exposure (four weeks post-TMZ/saline injections), rats were trained in the MWM
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for four days. Each day consisted of a block of four 60-second trials where the rat
searched for a submerged platform, 13 cm in diameter, hidden in a 180 cm
diameter pool of water dyed black with non-toxic paint. Once the rat located the
platform, he was allowed to remain on the platform for 15 seconds before being
placed back in his home cage to begin a four minute inter-trial interval. The maze
starting points (N, S, E, W) were the same for all animals in a given day, but each
day the sequence of starting points was different (counterbalanced in a Latin
square design). For example, day 1 was organized so that the entry points for the
four trials were N, S, E, W while entry points on day 2 were W, E, S, N. The
platform remained in the same position for all four days. On the final day,
approximately one hour after their last trial, the platform was removed and the rat
was placed back in the pool at a novel entry point (SW) for a probe trial. The
settings were fixed so that if a rat spent 5 seconds in the target zone (12.7 cm
zone around old platform location), the trial would end. If the rat did not spend 5
seconds in the target zone then the rat had 60 seconds to try and complete this
task. Animals were organized into blocks for behavioral testing so that each trial
contained a different treatment group, ensuring that no treatment group was run
consecutively. A video camera and a motion analyzer (EthoVision XT 10, version
10.1, Noldus, Wageningen, The Netherlands) connected to a Dell Precision
T3610 computer was used to measure distance to reach the platform (cm), time
to reach the platform (seconds), and velocity (cm/second). Daily blocks (four
trials) were averaged for each rat then averaged across treatment groups to
obtain daily means for distance, time, and speed ± standard error of the mean.
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4.2.3 Immunohistochemistry and quantification
Tissue was stained for NeuroD using previously described IHC methods
(Chapter 3). Previous studies have shown that NeuroD is increased 14 days after
binge alcohol exposure (Hayes et al., in prep) and therefore an increase at T14
likely represents T7 NPCs that have differentiated into a neuronal phenotype
(Gao et al., 2009). Quantification of NeuroD was performed differently for
experiments in this chapter. In Chapter 3, unbiased stereology was used to count
NeuroD+ cells and since NeuroD is expressed uniformly, with cell counts over
150 cells/section, West (1991) showed that this was an appropriate way to
accurately quantify the SGZ (West, 1991). However, profile cell counts represent
a logical alternative to stereology and provide a way to quantify the SGZ allowing
the experimenter to count all the cells in the region of interest (Crews et al.,
2004b). Importantly, counting all cells should theoretically be as accurate, if not
more accurate than only counting a sample of cells, even if it is randomly
generated. In this experiment, NeuroD+ cells were counted using profile cell
counts since the number of NeuroD+ cells was easily quantifiable, accuracy was
similar to stereology, and profile counting saved experimenter time.
BrdU+ (240 µm between sections) and NeuroD+ (480 µm between
sections) cells were quantified on a single hemisphere between Bregma -2.28
mm and -5.52 mm (as determined by Paxinos and Watson, 2009). For each rat,
all tissue sections were inspected and the side without tears to the SGZ was
selected for quantification. BrdU+ and NeuroD+ cells were then counted along
the SGZ, a band of cells approximately three cell widths that runs between the
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GCL and the hilus of the hippocampal dentate gyrus. Cells profiles were counted
manually at 1000x magnification with a 100x objective lens coupled to an
Olympus BX41 microscope. Brains were coded to blind the experimenter to the
treatment conditions during quantification. Data are presented as the average
number of immunopositive SGZ cells/section ± standard error of the mean.
4.2.4 Statistics
All data were analyzed with GraphPad Prism® (version 7.0, GraphPad
software, La Jolla, CA) or SPSS Statistics (version 22, IBM, Armonk, NY).
Intoxication parameters were analyzed by comparing ethanol groups using a
one-way ANOVA (ethanol dose and BEC) or the non-parametric Kruskal-Wallis
test (intoxication and withdrawal scores). BrdU+ (T7 and T14) and NeuroD+
(T14) cell counts were analyzed by two-way ANOVA (diet x drug) followed by
planned t-tests. It was expected that there would not be a significant interaction
between diet and drug because TMZ would likely decrease proliferation across
all conditions and therefore a priori t-tests were used to analyze the critical
comparisons (the most critical being between the ethanol + TMZ group and the
control + saline group). MWM data was analyzed by three-way repeated
measures ANOVA (diet x drug x day) and posthoc Bonferroni’s multiple
comparisons test, when appropriate. The MWM probe trial data was analyzed by
two-way ANOVA (diet x drug). P-values were accepted as significant when p <
0.05.
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4.3 RESULTS
4.3.1 TMZ normalizes alcohol-induced reactive proliferation at T7
Animals were administered 0, 25, or 50 mg/kg/d TMZ following binge
alcohol (or control) exposure to decrease alcohol-induced reactive proliferation
(Table 4.1 and Figure 4.1). Intoxication parameters were compared between
treatment groups to rule out potential confounding effects of model-differences
on TMZ’s effect on neurogenesis (Figure 4.2). One-way ANOVA of BEC and
alcohol dose as well as Kruskal-Wallis tests of intoxication score and withdrawal
score revealed no differences between groups. Therefore, T7 rats displayed a
mean intoxication score of 1.8 ± 0.06 on the 6-point intoxication scale (Figure
4.2) which is represented behaviorally by ataxia and an elevated abdomen. T7
rats received a mean daily ethanol dose of 9.7 ± 0.2 g/kg/d and displayed
average BECs of 354 ± 8 mg/dl. These values are similar to those previously
reported (Morris et al., 2010a).
Clusters of BrdU+ cells were located along the SGZ and were quantified
seven days after binge alcohol administration and 12 hours after the last
administration of TMZ to assess the effect of TMZ on alcohol-induced reactive
proliferation. A two-way ANOVA revealed a main effect of diet [F(1,37)=30.86; P <
0.0001] and a main effect of drug [F(2,37)=6.098; P=0.0051]. Planned t-tests
revealed no differences between 0 and 25 mg/kg/d TMZ for either ethanol or
control groups. However, there was a difference between 0 and 50 mg/kg/d TMZ
for both ethanol [t(14)=4.708; p=0.0003] and control [t(10)=5.316; p=0.0003] groups
such that the number of BrdU+ cells/section was significantly reduced in TMZ
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Figure 4.2 - T7 animal model data

Figure 4.2 - Animals were treated with four days of binge alcohol administration
followed by TMZ administration (0, 25, or 50 mg/kg/day). (A) Behavioral
intoxication scores (left axis) and corresponding ethanol dose (right axis) were
similar between groups. (B, C) Average daily ethanol dose and BEC did not differ
between groups. Arrow = when bloods were taken for BEC; n = 8-9 for ethanol
groups.
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Figure 4.3 - Representative images and BrdU+ cell counts for T7 optimization

Figure 4.3 - Representative photomicrographs of BrdU+ cells for control (A-C)
and ethanol (D-F) animals at indicated TMZ doses seven days post-alcohol
exposure. Large and inset images were taken with a 10x and 100x objective,
respectively. (G) The number of BrdU+ cells was significantly decreased
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(Figure 4.3 continued)
following 50 mg/kg/d TMZ. Note the lack of significance between ethanol + 50
mg/kg/d TMZ and control + saline; it suggests that proliferation returned to levels
seen in controls. Scale bar = 100 µm; inset 40 µm. GCL = granule cell layer.
*p = < 0.05; n = 8-9 for ethanol groups and n = 6 for control groups.
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versus saline animals. Additionally, a planned t-test revealed no significant
difference in BrdU+ cell counts between 50 mg/kg/d TMZ ethanol rats and saline
control rats (Figure 4.3), which indicates that TMZ decreased proliferation to
levels seen in control animals.
4.3.2 TMZ normalizes alcohol-induced reactive neurogenesis at T14
In order to verify the results from the previous experiment, rats were
administered 0 or 50 mg/kg/d TMZ to decrease alcohol-induced reactive
proliferation/neurogenesis. Intoxication parameters were again compared
between treatment groups to rule out potential confounding effects of model
differences on TMZ’s effect on cell proliferation and neurogenesis (Figure 4.4).
Student’s t-test of BEC and daily ethanol dose revealed no differences between
TMZ and Saline groups. Non-parametric (Mann-Whitney) tests of intoxication
scores and withdrawal scores also revealed no differences between TMZ and
saline groups. As such, data were collapsed across groups resulting in a mean
intoxication score of 1.7 ± 0.1 on the 6-point intoxication scale (Figure 4.4) which
is represented behaviorally by ataxia and an elevated abdomen. The T14 mean
daily ethanol dose was 9.8 ± 0.3 g/kg/d ethanol, and the corresponding mean
BEC was 376 ± 17 mg/dl. These values are similar to those previously reported
(Morris et al., 2010a) and those reported in the previous experiment (T7).
NeuroD is expressed in newborn neurons and is used as an early marker
of neurogenesis (Gao et al., 2009; Pataskar et al., 2016). NeuroD+ cells were
stained by immunohistochemistry 14 days after ethanol exposure.
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Figure 4.4 - T14 animal model data

Figure 4.4 - Rats were treated with binge alcohol or control diet for four days
followed by saline or 50 mg/kg/day TMZ. (A) Behavioral intoxication scores (left
axis) and corresponding ethanol dose (right axis) were similar between groups.
(B, C) Average daily ethanol dose and BEC did not differ between groups.
n = 8/group.
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NeuroD+ cells were seen along the SGZ and the inner GCL and were consistent
with markers of neuroblasts or immature neurons. NeuroD+ cells were quantified
by profile cell counts which revealed decreased NeuroD+ cell counts in rats
administered TMZ vs saline (Figure 4.5). Representative images show NeuroD+
nuclear staining throughout the SGZ in control diet (Figure 4.5 A, C) or ethanol
diet (Figure 4.5 B, D) followed by saline or TMZ. Two-way ANOVA (diet x drug)
revealed a main effect of diet [F(1,28)=12.70; p=0.0013] and a main effect of drug
[F(1,28)=20.41; p=0.0001]. A planned t-test revealed that administration of ethanol
+ TMZ resulted in NeuroD+ cell counts similar to control + saline [t(14)=1.19;
p=0.25], indicating that neurogenesis levels were similar to those seen in control
animals. Additional planned t-tests revealed that administration of TMZ
decreased NeuroD+ cell counts for both control [t(14)=2.79; p=0.014] and ethanol
[t(14)=3.64; p=0.0027] groups. This means that regardless of diet (ethanol or
control), the rats injected with TMZ had decreased NeuroD+ cell counts when
compared to rats injected with saline.
The number of BrdU+ cells were counted 14 days post-binge. BrdU+ cells
were again observed all along the SGZ (Figure 4.6 A-D). There was a significant
difference between saline and TMZ, but only in ethanol-exposed rats (Figure
4.6). Two-way ANOVA (diet x drug) revealed a main effect of diet [F(1,27)=4.28;
p=0.048] and a main effect of drug [F(1,27)=17.69; p=0.0003]. A planned t-test
revealed that administration of ethanol + TMZ resulted in cell counts not
significantly different from control + saline [t(14)=1.76; p=0.1], indicating that
proliferation levels returned to those observed in controls. Additional planned
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Figure 4.5 - Representative images and NeuroD+ cell counts at T14

Figure 4.5 - Rats were treated with binge alcohol or control diet for four days
followed by saline or TMZ injections and were sacrificed 14 days post-binge
(T14). Representative images show NeuroD+ nuclear staining throughout the
SGZ in control diet (A, C) or ethanol diet (B, D) followed by saline or TMZ. (E)
TMZ decreased NeuroD+ cell counts in control and ethanol groups. Additionally,
TMZ decreased NeuroD+ cell counts in ethanol-exposed rats to levels seen in
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(Figure 4.5 continued)
control + saline rats. Scale bar = 100 µm; inset = 40 µm. *p < 0.05; n = 8/group.
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Figure 4.6 - Representative images and BrdU+ cell counts at T14

Figure 4.6 - Representative images show BrdU+ cells 14 days after four-day
binge treatment with control (A, C) or ethanol diet (B, D) followed by saline or
TMZ injections. (E) Quantification of BrdU+ cell counts. Dashed line indicates T7
data to illustrate magnitude of T7 increase compared to T14. Scale bar = 100
µm; inset = 40 µm. *p < 0.05; n = 7-8/group.
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t-tests revealed that administration of TMZ significantly decreased BrdU+ cell
counts for ethanol [t(13)=4.642; p=0.0005] but not control groups. Figure 4.6 E
includes a dashed line that represents the large increase in BrdU+ cells seen in
the ethanol + saline group on T7. This dashed line indicates BrdU+ cell counts
that would be expected if reactive proliferation was delayed one week.
4.3.3 TMZ does not affect Morris water maze behavior at T38
In order to determine if inhibiting reactive neurogenesis would impact
hippocampal-dependent learning and memory, rats were set aside for four weeks
after TMZ administration to allow newborn neurons time to mature. Rats were
then tested on a hippocampal-dependent version of the MWM to assess whether
inhibiting reactive neurogenesis prevented functional recovery. To that end,
intoxication parameters were compared between treatment groups to rule out
potential confounding effects of model differences on TMZ treatment and
behavior (Figure 4.7). Student’s t-test of BEC and daily alcohol dose revealed no
differences between TMZ and saline groups. Non-parametric (Mann-Whitney)
tests of intoxication score and mean withdrawal score also revealed no
differences between TMZ and saline groups. There was a small but significant
decrease in peak withdrawal score for the TMZ group compared to saline
controls [U=19.5; p=0.028; Figure 4.7 E]. To that end, data resulted in a mean
intoxication behavioral score of 1.87 ± 0.09 on the 6-point intoxication scale
(Figure 4.7), which is represented behaviorally by an elevated abdomen and
ataxia. The mean daily ethanol dose was 9.4 ± 0.3 g/kg/d ethanol, and
corresponded to a mean BEC of 429 ± 11 mg/dl. The intoxication scores and
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Figure 4.7 - T38 animal model data

Figure 4.7 – Similarity of ethanol groups shown. Behavioral intoxication scores
(A, left axis) and corresponding ethanol dose (right axis) were similar between
groups. Average daily ethanol dose, BEC, and mean withdrawal score did not
differ between groups (B-D). Peak withdrawal scores were slightly, but
significantly lower in animals that received TMZ (E). *p < 0.05; n = 9-11/group.
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daily ethanol dose are similar to previous reports (Morris et al., 2010a) and
previous experiments with the exception that the BECs appeared slightly higher.
The mean withdrawal score was 1.3 ± 0.2 on the behavioral withdrawal scale
(Table 2.2). Peak withdrawal scores for ethanol + TMZ and ethanol + saline
cohorts were 3.75 ± 0.03 and 3.24 ± 0.2, respectively.
Following four days of binge alcohol exposure, temozolomide (or saline
vehicle) was administered to decrease/inhibit reactive neurogenesis. Thirty-five
days post-binge ethanol/control exposure the rats underwent training and testing
in the MWM (Figure 4.8). Thirty-five days post-binge was chosen as the endpoint since newborn neurons require approximately 28 days to become mature
neurons (Jessberger and Kempermann, 2003) and young neurons become
activated in response to the MWM as early as four weeks of age (Kee et al.,
2007). Three-way repeated measures ANOVA (day x diet x drug) revealed a
main effect of day (within-subjects) for distance to goal [F(3,108)=81.3; p<0.001],
time to goal [F(3,108)=93.8; p<0.001], and velocity [F(3,108)=48.7; p<0.001]. There
was no main effect of diet or drug (between-subjects) for distance to goal, time to
goal, or velocity. Essentially, distance, time, and velocity all showed changes
across the days of testing, but didn’t show differences between treatment
conditions (i.e. ethanol/control and/or TMZ/saline). To clarify, this means that
during the MWM at T35, rats given ethanol and TMZ injections did not differ from
those given control diet and saline injections. Probe trial data was analyzed by
two-way ANOVA (diet x drug) and revealed no differences between treatment
groups in terms of time spent in goal zone (5-inch area where platform was
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Figure 4.8 - T38 Morris water maze data

Figure 4.8 - Effects of binge ethanol and TMZ on Morris water maze behavior five
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(Figure 4.8 continued)
weeks post-binge. Three-way repeated measures ANOVA (day x diet x drug)
revealed a main effect of day (within-subjects) for (A) distance to goal, (B) time to
goal, or (C) velocity, indicating that all groups successfully learned to locate the
hidden platform. There was no main effect of diet or drug (between-subjects) for
distance to goal, time to goal, or velocity. n = 9-11/group.
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previously located), latency to reach the goal zone, or swim velocity. In
conclusion, ethanol rats did not differ from controls and although TMZ
successfully normalized (reduced) reactive neurogenesis, it did not prevent
normalization/recovery of MWM behavior (i.e. MWM behavior recovered without
reactive neurogenesis).
4.4 DISCUSSION
The key finding of this series of experiments is that TMZ decreased
alcohol-induced reactive neurogenesis but that did not alter MWM behavior. This
study indicates that TMZ decreased alcohol-induced reactive proliferation (BrdU+
cell counts) and corresponding neurogenesis (NeuroD+ cell counts) to levels
seen in controls. These findings are consistent with previous reports showing that
TMZ is able to decrease neurogenesis (Garthe et al., 2009, 2016; Niibori et al.,
2012; Nokia et al., 2012). However, previous studies showed that TMZ
decreased basal neurogenesis, while the present studies demonstrate decreases
in reactive neurogenesis. In fact, this experiment represents the first time that
TMZ was used in combination with alcohol exposure to study reactive
neurogenesis. Aside from the fact that alcohol was administered during the
present experiments, the results from both studies demonstrate that TMZ yields a
general decrease in proliferation/neurogenesis. Currently, there is no way to
identify and therefore selectively inhibit proliferation of cells undergoing reactive
proliferation. Therefore, TMZ was used to inhibit proliferation/neurogenesis
overall and, consequently, decreased proliferation was expected in all animals
given TMZ (including control diet groups). TMZ’s non-selective inhibition of
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proliferation is a limitation of the study; however, it was the best option available.
Nevertheless, it is noteworthy that TMZ was able to bring reactive proliferation
down to control levels, especially since extra doses of ethanol were not able to
achieve this task. Now, TMZ represents a tool to inhibit reactive neurogenesis
and can be used for studies wanting to investigate the mechanistic basis of
alcohol-induced reactive proliferation.
An additional concern was that TMZ would merely delay reactive
proliferation. Therefore, since alcohol-induced reactive proliferation occurs seven
days post-binge, we assessed proliferation by counting BrdU+ cells seven days
after TMZ administration, on T14. We observed a small but significant decrease
in proliferation in the ethanol + TMZ group compared to the ethanol + saline
group on T14. Although statistically significant, this ~10 cell/section difference at
T14 is nowhere near the ~70 cell/section increase in proliferation observed at T7,
plus it is in the opposite direction. Additionally, previous studies have examined
this same time point (T14) and have not seen any differences in proliferation
between ethanol and control rats (McClain et al., 2014; Nixon and Crews, 2004;
Nixon et al., 2008), so this could represent an incongruity where proliferation in
these animals simply happened to be on the low side. Alternatively, the decrease
in proliferation could be the result of the pool of proliferating cells becoming
exhausted since a week earlier there was a large increase in proliferation
(Kempermann, 2008). Although, one would have expected to observe this
proliferation at T14 previously, and that has not been the case.
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Proliferation levels (BrdU) at T7 following alcohol/control diet and
TMZ/saline administration are mirrored at T14 with the neurogenesis marker,
NeuroD. Previous studies have shown that NeuroD is increased at T14 (Chapter
3 and Hayes et al., in prep) and therefore an increase at T14 likely represents the
increase in proliferating NPCs at T7 that have differentiated into immature
neurons (McClain et al., 2014; Nixon and Crews, 2004). NeuroD at T14
demonstrated that TMZ decreased reactive neurogenesis (Figure 4.5).
Importantly, ethanol rats given TMZ showed no difference in NeuroD+ cell counts
from control + saline rats indicating that administration of TMZ through this
protocol effectively inhibits the increase in alcohol-induced reactive neurogenesis
seen at T14. Taken together with the T7 BrdU data this likely indicates that TMZ
decreases alcohol-induced reactive neurogenesis to levels seen in control-saline
rats. Not surprisingly, and in agreement with other TMZ-neurogenesis reports
(Garthe et al., 2009, 2016; Martinez-Canabal et al., 2013; Niibori et al., 2012;
Nokia et al., 2012), a decrease in neurogenesis (NeuroD+ cells at T14) was also
seen in control animals (non-ethanol) receiving TMZ. Although unavoidable,
some may view this as a methodological weakness since TMZ administration
could result in behavioral deficits in-and-of-itself, which would complicate
interpretation. Indeed, if TMZ alone caused behavioral deficits at the doses
administered then the drug could not be used since one would not be able to
determine if behavioral deficits were caused by TMZ or by inhibition of reactive
neurogenesis. However, we did not observe behavioral differences between any
groups in the MWM, indicating that it is unlikely that TMZ alone causes
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behavioral deficits. Surprisingly, MWM training and testing 35-38 days post-binge
did not reveal a deficit in animals where reactive neurogenesis was decreased to
control levels (Figure 4.8). Here we showed that a single round of TMZ did not
appear to affect learning and memory in a hippocampal-dependent version of the
water maze task. This finding is supported by a study that used eyeblink classical
conditioning, specifically, trace and very long delay conditioning, both
hippocampal-dependent tasks, to study the effects of TMZ on learning and
memory (Nokia et al., 2012). They showed that administration of a single 3-day
cycle of TMZ was not sufficient to induce deficits, however, multiple cycles of
TMZ (over several weeks) did, in fact, disrupt learning (Nokia et al., 2012). This
study supports our findings that the one cycle of TMZ used in our study should
not be detrimental to learning and memory.
Interestingly, despite TMZ’s ability to decrease reactive neurogenesis,
there were no differences between any experimental groups in MWM training or
testing. MWM is the ‘gold-standard’ measure of hippocampal-dependent learning
and memory (Nunez, 2008). These data, combined with previous research from
our lab which show a MWM deficit 7-10 days post-binge (Supplemental Figure
1), indicates that alcohol-exposed rats recover hippocampal function, at least in
the MWM, by T35. Indeed, previous research has shown that hippocampal
function recovers in humans (Gazdzinski et al., 2008) and in animal models of
AUDs (Cadete-Leite et al., 1988, 1989a, 1989b; King, 1988).
Binge alcohol treatment was not considered a confounding variable since
intoxication data between treatment groups was similar for the vast majority of
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measures (all except peak withdrawal score). Only a slight difference was seen
during peak withdrawal between the two ethanol groups (T35 saline and T35
TMZ) and no other differences in intoxication measures were observed, including
mean withdrawal. Therefore, it is likely that the two T35 ethanol groups showed a
difference in peak withdrawal score due to one groups unusually consistent peak
withdrawal scores and/or random group assignments. Indeed, all ethanol + saline
animals achieved the exact same peak withdrawal score, resulting in no error
and therefore significance between saline and TMZ groups. TMZ was given after
withdrawal and rats were randomly assigned to a TMZ or saline group. All groups
learned similarly, whether they received alcohol followed by TMZ injections or
control diet followed by saline injections. Slight differences in peak withdrawal
score, although significant, do not explain the MWM data since no differences
were observed between groups. However, a thorough analysis of TMZ’s effects
on basal neurogenesis and learning literature indicated that even with multiple
weeks of TMZ administration, differences between treatments (TMZ vs. saline)
were primarily seen when the platform location was changed in the MWM during
a reversal task (Garthe et al., 2009, 2016). This indicates that the standard water
maze test may not have been challenging enough to flush out differences
between the treatment groups and a harder version of the water maze may be
necessary to tease apart subtle deficits in learning and memory (Garthe et al.,
2009, 2016). Therefore, the hypothesis that reactive neurogenesis is necessary
for normalization of learning and memory involved in the MWM may still be valid
and reactive neurogenesis could be required for proper hippocampal function. In
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addition, since reversal learning was not tested in this study, it is possible that a
single cycle of TMZ could still induce behavioral deficits. However, since TMZ
was only administered for a single 3.5 day cycle in this study, as opposed to
several weeks, it seems unlikely that TMZ alone would induce behavioral deficits
in a reversal learning task (Nokia et al., 2012). Indeed, Nokia et al., 2012
demonstrated that the detrimental effects of TMZ were only seen after several
weeks of treatment. Despite that information, at this time we cannot rule out the
possibility that TMZ could induce behavioral deficits since TMZ has not been
studied following a binge model of an AUD. As such, any future experiments
should include a more challenging reversal water maze task.
In conclusion this novel TMZ administration paradigm was able to
decrease alcohol-induced reactive neurogenesis. Additionally, there was not a
rebound in reactive proliferation one week following TMZ administration.
Interestingly, treatment with TMZ had no detectable effect on MWM behavior 35
days after alcohol exposure. Future experiments will increase the difficulty of the
water maze by adding a reversal component, since binge alcohol exposure could
cause subtle deficits in hippocampal function that may be difficult to detect
without the appropriately challenging test.

Copyright © Chelsea Rhea Geil Nickell 2016
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CHAPTER 5: MWM-INDUCED NEURONAL ACTIVATION FOLLOWING
ALCOHOL-INDUCED REACTIVE NEUROGENESIS
5.1 INTRODUCTION
Alcohol-induced neurodegeneration is characterized by decreased MRI
brain volumes, decreased hippocampal granule cell counts, and deficits in
learning and memory (Pfefferbaum et al., 1992; Walker et al., 1980; Zahr et al.,
2015). Neurogenesis is one of the ways that alcohol leads to neurodegeneration
since alcohol intoxication results in decreased levels of adult neurogenesis. But,
following a 4-day binge model of an AUD, when alcohol is removed there is a
reactive increase in neurogenesis and its role in repair is unknown. This alcoholinduced reactive increase in neurogenesis occurs seven days post-binge (T7)
and results in new, mature neurons 28 days later (Nixon and Crews, 2004).
However, it is also not known if neurons born during alcohol-induced reactive
neurogenesis are functionally incorporated. This lack of knowledge regarding the
function of neurogenesis is due to the fact that, in general, it has been technically
difficult to study, and as such the function of adult-born neurons is still up for
debate (as discussed in Chapter 2). Nevertheless, most agree that adult
neurogenesis has been evolutionarily conserved for good reason and that it
serves multiple functions (Kempermann, 2008).
Under basal adult neurogenesis conditions (i.e. when alcohol is not
involved) newborn neurons integrate into the hippocampal circuitry. At around
three weeks post-birth they sprout axons that project along the mossy fiber tract
towards the CA3 region, and they also become capable of receiving excitatory
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input from the perforant pathway (Hastings and Gould, 1999; Kaplan and Hinds,
1977; Kee et al., 2007; van Praag et al., 2002). For over two decades,
researchers have used double-label IHC technology along with immediate early
genes (IEGs), like c-Fos, as markers of neuronal activity (Cruz et al., 2013;
Guzowski et al., 2005). IEGs are genes that are activated quickly and briefly by a
variety of cellular stimuli; many are transcription factors or other kinds of DNA
binding proteins (Guzowski et al., 2005). The expression of IEGs like c-Fos and
Zif268 are correlated with neuronal excitation and can be used to indicate
neuronal activation (Guzowski, 2002; Kee et al., 2007; Labiner et al., 1993). CFos is involved in learning and memory and as such has been used as a
neuronal activity marker (Guzowski et al., 2005). Under baseline conditions, IEG
expression levels are generally undetectable immunohistochemically. However,
increases in IEG expression occur quickly if the brain is in an attentive state
and/or if synaptic plasticity is induced (Cole et al., 1989; Guzowski et al., 1999).
Since IEGs are highly conserved evolutionarily, they have been used to study
neural circuits in many animal species (Guzowski et al., 2005).
We investigated whether new neurons produced during alcohol-induced
reactive neurogenesis are incorporated functionally following a hippocampaldependent task of spatial learning and memory, the MWM. Here we used c-Fos
as an indicator of neuronal activity since it is selectively upregulated in granule
cells of the dentate gyrus following the MWM (Geibig et al., 2012; Kee et al.,
2007). Studies have also shown that 6-8 week old granule cells are preferentially
recruited and activated following the MWM task in mice (Kee et al., 2007).
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Therefore, we used the MWM to induce (activate) c-Fos expression and then
determined if the neurons born during reactive neurogenesis are capable of
being activated in response to the MWM. To induce activation we selected the
MWM since there is a clear increase in granule cell activation following this task
(Kee et al., 2007). Then, we identified these activated cells by triple-label IHC
which results in a precise population of neurons being labeled (Geibig et al.,
2012). We used BrdU to label cells proliferating on T7 during reactive
neurogenesis. These young neurons, born and labeled on T7, were then allowed
to mature/integrate into hippocampal networks for six weeks, an amount of time
that has been shown to be sufficient for preferential incorporation for the MWM
(Kee et al., 2007). After the neurons had time to integrate, the rats were tested in
the MWM. Only newborn cells that were labeled with BrdU during reactive
neurogenesis (on T7), survive six weeks, express a mature neuronal marker
(NeuN), and were activated in response to a hippocampal-dependent task
(MWM) were triple labeled. Therefore, we examined the contribution of reactive
neurogenesis to learning the MWM task, after neurons had 6 weeks to mature.
Using the IEG c-Fos, we determined if neurons born during reactive
neurogenesis were incorporated into hippocampal networks and if the number
and percentage of neurons activated was different from controls. We
hypothesized that reactive neurogenesis produced neurons capable of
hippocampal integration (activation) following the MWM task.
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5.2 METHODS
5.2.1 Binge model of an Alcohol Use Disorder
Twenty-one male Sprague-Dawley rats (Charles River Laboratory)
weighing 275-300 grams on arrival, were double-housed and allowed to
acclimate to the University of Kentucky AAALAC-accredited vivarium for five
days before experimental procedures began. All experimental procedures were
completed in accordance with the University of Kentucky Institutional Animal
Care and Use Committee and followed the Guidelines for the Care and Use of
Laboratory Animals (NRC, 1996). Animals were divided into two groups with
statistically similar weights and administered either 25% (w/v) ethanol in Vanilla
Ensure Plus® (Abbott Laboratories, Columbus, OH) or an isocaloric control diet
(calorically equivalent quantities of dextrose) in Vanilla Ensure Plus®. Ethanol
(n=10) or control diet (n=11) was administered every eight hours for four
consecutive days (previously described). Ninety minutes following the seventh
dose of ethanol, tail bloods were collected to determine BEC (as previously
described in Chapter 2). An average of the triplicate samples are presented as
BEC ± standard error of the mean.
All ethanol animals underwent monitored withdrawal for 17 hours
beginning 10 hours after the last dose of ethanol (previously described in
Chapter 2). Briefly, rats were observed for 30 minutes every hour for 17 hours
and withdrawal behavior (listed in Table 2.2) was scored. Data are reported as
mean or peak withdrawal score ± standard error of the mean.
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5.2.2 Bromodeoxyuridine administration
The proposed dose of BrdU has been shown not to result in toxicity or to
label DNA repair using IHC methods (Cameron and McKay, 2001; Palmer et al.,
2000). Beginning exactly 168 hours (7 days) after the last dose of alcohol, all
animals received the first of three total i.p. BrdU injections (100 mg/kg BrdU in
0.9% saline), scheduled injections were eight hours apart at 7AM, 3 PM, and
11PM (Figure 4.1). BrdU gets incorporated into the DNA in place of Thymidine
when the cell is in the synthesis phase (S-phase) of the cell cycle. Typical
duration of the S-phase in adult rats is eight hours (Cameron and McKay, 2001)
and therefore BrdU injections were administered every eight hours to label a
large pool of cells proliferating on T7 (seven days post-binge alcohol exposure).
Administering saturating doses of BrdU (200-300 mg/kg), i.e. doses known to
label all proliferating cells, was not possible due to BrdU’s poor solubility (max 20
mg/ml) which would necessitate large volumes being repeatedly injected into the
i.p. cavity. However, several studies administered much lower concentrations of
BrdU and achieved measurable results (Jessberger and Kempermann, 2003;
Kee et al., 2002; Weig et al., 2016). Thus, multiple BrdU injections of 100 mg/kg
should label a large pool of cells that could potentially be recruited for use in the
MWM.
5.2.3 Morris water maze
The MWM was used to activate neurons generated during alcohol-induced
reactive neurogenesis (Figure 5.1). The MWM was performed as described in
Chapter 4. Briefly, seven weeks post-binge alcohol exposure (when newborn
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Figure 5.1 - Experimental design for functional neurogenesis study

Figure 5.1 - Four days of binge alcohol exposure were followed by three BrdU
injections seven days post-binge (T7) during reactive proliferation. Proliferating
cells were allowed to mature for six weeks and then animals were all trained and
tested in the Morris water maze for four days. One hour after their last trial on the
fourth day, the platform was removed and all rats were tested in a probe trial. All
animals were sacrificed (sac) approximately 90 minutes after their last MWM trial
(not including the probe trial) on the fourth day.
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neurons are six weeks old) the rats were trained and tested in the MWM for four
days. Daily blocks (four trials) were averaged for each animal then averaged
across treatment groups (control and ethanol diet) to obtain daily means for
latency (s), distance (cm), and swim speed (cm/s) ± standard error of the mean.
On the final day, approximately one hour after their last trial, the platform was
removed and the rats were placed back in the pool at a novel entry point (SW) for
a probe trial. The settings were fixed so that if a rat spent 5 seconds in the target
zone (12.7 cm zone around old platform location), the trial would end. If the rat
did not spend 5 seconds in the target zone then the rat had 60 seconds to try and
complete this task.
5.2.4 Tissue preparation
Fifty-two days following their last dose of alcohol and ~90 minutes after
their last trial in the MWM (not including the probe trial), rats were sacrificed by
pentobarbital overdose (Fatal Plus®) followed by intracardial perfusion
(previously described). Ninety minutes was selected based on previous research
that demonstrated its appropriateness for examining c-Fos expression in
hippocampal neurons (Snyder et al., 2009). Brains were then extracted, postfixed, and sliced in 40 µm sections on a vibrating microtome as previously
described in Chapter 2.
5.2.5 Immunohistochemistry
A subset of three ethanol rats and three control rats were selected for
triple-label IHC based on their pre-binge weights being closest to the average.
Care was also taken to ensure that the three selected ethanol rats had
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intoxication and withdrawal scores that were close to the averages. Tissue was
stained using triple label fluorescent IHC for BrdU, c-Fos, and NeuN, similar to
Geibig et al. (2012). Individual dilution curves were run for each primary antibody
(BrdU, c-Fos, and NeuN) to determine the best working concentration. The
foundation of the triple label protocol was the BrdU antibody protocol since it was
the most rigorous. Free-floating tissue sections were rinsed in phosphate
buffered saline (PBS) pH 7.4 (Gibco, Life Technologies, Grand Island, NY) + 1%
Triton®X-100 (Acros Organics, New Jersey, US), PBST. Tissue was then
incubated for 30 minutes in 1 N HCl at 37º C (to denature DNA so the anti-BrdU
antibody can bind) and neutralized with 0.1 M Boric acid pH 8.5. Tissue was then
rinsed in PBST and incubated in primary antibody for three hours at room
temperature followed by 42 hours at 4º C. The primary antibodies: rabbit anti-cFos (1:200, SC7202, Santa Cruz Biotechnology Inc., Dallas, TX), rat anti-BrdU
(1:400, H7786, Accurate Chemical and Scientific Co., Westbury, NY), and mouse
anti-Neuronal Nuclei (1:10,000, MAB377, Millipore, Tememecula, CA), were
diluted in 15% normal goat serum (Vector Laboratories, Burlingame, CA) in
PBST. Tissue was rinsed in PBST and incubated in a light-proof box at room
temperature for 90 minutes in secondary antibody. From this point on all light
exposure was limited. Secondary antibody solution consisted of 15% normal goat
serum in PBST and 1:200 of the following Alexa Fluor’s® (Invitrogen™ Molecular
Probes®, Eugene, OR): goat anti-rabbit IgG 488, goat anti-rat IgG 546, and goat
anti-mouse IgG 633. Tissue was rinsed in PBST, mounted onto glass slides,
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allowed to dry, coverslipped with ProLong® Gold antifade reagent (Molecular
Probes® by Life Technologies, Eugene, OR), and left to cure for two nights.
5.2.6 Quantification
Brains were sliced at 40 µm thickness and collected in a 1:12 series
resulting in approximately 6-8 hippocampal sections per brain. All sections per
brain were inspected and the side without tears to the SGZ was selected for
quantification. All cells were quantified using a Leica TCS SP5 inverted laser
scanning confocal microscope (Wetzlar, Germany). Z-plane optical stacks were
collected at 1 µm thickness using a 20x objective. Multiple z-stacks were taken
across each section to capture the entire GCL (2-5 z-stacks per section, 6-8
sections per brain). Immediately, after each z-stack the images were visually
inspected to determine if any triple labeling occurred. This was accomplished
using Leica software by hiding the NeuN (blue) channel and looking for overlap
of BrdU+ (red) and c-Fos+ (green) cells = yellow. Yellow was much easier to
detect than the white color made by blue/red/green and was just as accurate for
detecting a cell that needed further investigation. If it was suspected that a cell
may be triple labeled, then the suspect cell underwent another z-stack at a higher
magnification (63x lens). All cells were quantified on a single hemisphere (480
µm between sections), between Bregma -2.28 mm and -5.52 mm as determined
by Paxinos (Paxinos and Watson, 2009).
All Z-stack images were viewed and manually quantified using Image-Pro
Plus software (version 3.6 windows, Image-Pro Plus, Media Cybernetics,
Rockville, MD). Although Image-Pro Plus software can be used to generate a 3D
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render of collected z-stack images, this type of analysis was not feasible because
of the very high concentration of NeuN+ cells. The GCL consists of densely
packed granule cell neurons and since these are what NeuN labels, the signal
takes over the 3D render making it very difficult to assess with 3D rendering
software. Nevertheless, Image-Pro Plus software was still used because it makes
viewing z-stack images easier. This software allowed viewing all three cell
marker images and the overlay simultaneously; overlay images help determine if
a single cell expressed more than one marker (co-labeling). Essentially, each
marker BrdU, c-Fos, and NeuN was a different color image. For each z-stack, the
series of images were compiled such that each color/marker (including the
overlay) could be visualized and used to count all BrdU+ and c-Fos+ cells in the
GCL (see Figure 5.3 for examples of each color channel/image and
corresponding overlay and how this method can be used to count cells). NeuN
cells were not counted because NeuN immunoreactivity was only used to confirm
that the cell was a mature neuron. Each BrdU+ cell was assessed for its
expression of c-Fos and NeuN. Similarly, each c-Fos+ cell was assessed for its
expression of BrdU and NeuN. All BrdU+ and c-Fos+ cells were counted and
then each cell was determined to be either BrdU+/NeuN+, BrdU only, cFos+/NeuN+, c-Fos only, or c-Fos+/BrdU+/NeuN+ (similar to Geibig et al., 2012).
Cell counts were then totaled for each animal (2-5 z-stacks per brain section, 6-8
sections per animal) and averages for control and ethanol animals were
calculated ± standard error of the mean.
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5.2.7 Statistics
All data were analyzed with GraphPad Prism (version 7, GraphPad
Software, La Jolla, CA) and reported as mean ± standard error of the mean.
Histological data were analyzed by student’s t-test. MWM data were analyzed by
two-way repeated measures ANOVA (diet x day) and when appropriate, followed
by Bonferroni’s multiple comparisons test. MWM probe trial data were analyzed
by one-way ANOVA (diet). P-values were accepted as significant when p < 0.05
(two-tailed).
5.3 RESULTS
5.3.1 Animal model data
Adult male Sprague-Dawley rats were fed an ethanol or control diet for
four days with the ethanol dose titrated based on the rat’s intoxication score.
Ethanol-fed rats had a mean intoxication score of 1.8 ± 0.07, which resulted in an
average ethanol dose of 9.7 ± 0.2 g/kg/d, and average BECs of 401 ± 14 mg/dl.
Mean withdrawal scores were 1.4 ± 0.2 and peak withdrawal scores were 3.6 ±
0.1 on the behavioral withdrawal scale (Table 2.2). With the exception of BECs
being slightly higher than usual, these values are similar to previous reports
(Morris et al., 2010a).
5.3.2 Morris water maze at T52
MWM was used to activate neurons born during alcohol-induced reactive
neurogenesis. Animals were trained and tested in the MWM for four days
beginning seven weeks post-binge (six weeks post-BrdU injections). Two-way
repeated measures ANOVA revealed a main effect of day for time to goal
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(latency) [F(3,57)=64.2, p<0.0001], distance to goal [F(3,57)=63.8, p<0.0001], and
swim speed [F(3,57)=42.4, p<0.0001]. There was a significant diet x day interaction
for time to goal (latency) [F(3,57)=4.7, p<0.05], distance to goal [F(3,57)=4.7,
p<0.05], and swim speed [F(3,57)=3.8, p<0.05]. The Bonferroni post-hoc multiple
comparisons test revealed that ethanol-fed animals had decreased time to goal
compared to controls on day 1 and 2 (p<0.05, Figure 5.2 A), which indicated that
during the first two days of MWM, rats exposed to four days of ethanol (seven
weeks earlier) took less time to locate the platform than rats fed a control diet.
Additionally, a decrease was seen in distance to goal and velocity in alcohol-fed
animals compared to controls on day 2 (p<0.05, Figure 5.2 B, C), indicating that
ethanol animals did not locate the platform more quickly simply because they
were swimming faster. If anything the ethanol animals appeared to swim slower
and swam shorter distances. Probe trial one-way ANOVA did not reveal any
differences between ethanol and control.
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Figure 5.2 - T52 Morris water maze results

Figure 5.2 - The MWM was used as a tool to activate hippocampal neurons, still,
MWM data was collected and is reported here. Rat performance on the MWM
was assessed by three measures: (A) time to goal (latency), (B) distance to goal,
and (C) swim speed. *p < 0.05, n = 10-11/group.

126

5.3.3 Fluorescent triple label (BrdU/c-Fos/NeuN)
Representative photomicrographs are detailed in Figure 5.3 and include
(A) a BrdU+/NeuN+ cell, (B) c-Fos+/NeuN+ cells, and (C) a BrdU+/cFos+/NeuN+ cell. The total number of BrdU+ cells was counted across the GCL
and each BrdU+ cell was assessed for the presence of NeuN, a marker of
mature neurons. Ethanol rats showed an increase [t(4)=3.34; p=0.029] in the
number of BrdU+ cells compared to controls at T52, six weeks after reactive
neurogenesis (Figure 5.4 A). Additionally, ethanol animals revealed an increase
[t(4)=5.347; p=0.0059] in the number of BrdU+/NeuN+ cells compared to controls
(Figure 5.4 B). BrdU indicated which cells were proliferating on T7 and then
survived to T52, while the combination of BrdU+/NeuN+ cells indicated that the
BrdU+ cells became mature neurons. The total number of BrdU+ cells and the
total number of c-Fos+ cells was also counted across the GCL. C-Fos+ cells and
c-Fos+/NeuN+ cell counts (Figure 5.4 C, D) revealed no differences between
ethanol and control animals, suggesting that ethanol consumption did not alter
the number of cells activated by the MWM. There was no significant difference
[t(4)=0.591; p=0.5861] in the number of triple labeled cells (BrdU+/c-Fos+/NeuN+)
between ethanol and controls (Figure 5.4 E). Additionally, the percentage of
BrdU+ cells that also expressed c-Fos and NeuN (i.e. cells that were triple
labeled) was not different between ethanol and control groups (Figure 5.4 F).
Overall, very few cells were triple labeled, which is consistent with previous
studies (Geibig et al., 2012).
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Figure 5.3 - Representative images for BrdU/c-Fos/NeuN at T52

Figure 5.3 - Representative photomicrographs of the GCL at T52 for individual
fluorochromes illustrating BrdU+ cells (red), c-Fos+ cells (green), NeuN+ cells
(blue), and merged. (A) BrdU+/c-Fos-/NeuN+ cells, (B) BrdU-/c-Fos+/NeuN+
cells, and (C) BrdU+/c-Fos+/NeuN+ cells. Scale bars = 40 µm.
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Figure 5.4 - Triple label cell counts for BrdU/c-Fos/NeuN at T52

Figure 5.4 - Total cell counts are included in the following graphs for: (A) BrdU+
cells, (B) BrdU+/NeuN+ cells, (C) c-Fos+ cells, (D) c-Fos+/NeuN+ cells, and (E)
c-Fos+/BrdU+/NeuN+ cells. Note the percentage of BrdU+ cells that also
expressed c-Fos and NeuN (i.e. cells that were triple labeled) are included in the
last graph (F). *p < 0.05; n = 3/group.
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5.4 DISCUSSION
Ethanol rats displayed increased neurogenesis, indicated by
BrdU+/NeuN+ cell counts seven weeks-post binge, confirming that reported
previously (Nixon and Crews, 2004). Indeed, more than 90% of BrdU+ cells coexpressed NeuN, which means that 90% of the cells labeled on T7 that survived
to T52 (in the SGZ) became mature neurons. This is consistent with previous
studies that show increases in neurogenesis following alcohol exposure
(Hansson et al., 2010; He et al., 2005; Maynard and Leasure, 2013; Nixon and
Crews, 2004). Although there was an increase in neurogenesis in ethanol rats,
there was no difference between ethanol and control rats in terms of the number
of cells that were activated in response to the MWM (measured with c-Fos;
Figure 5.4). Studies have shown that c-Fos expression is similar between
newborn neurons and older granule cells following MWM in untreated (normal)
animals (Jessberger and Kempermann, 2003). However, assessing the number
of c-Fos+ cells was not the goal here, the goal was to determine if more of the
newborn neurons (labeled on T7) were activated by MWM. Interestingly, despite
the increase in neurogenesis (BrdU+/NeuN+) there was no increase in the
number of triple labeled neurons, i.e. activated neurons. In summary, there were
significantly more six-week old neurons in ethanol rats and those neurons were
the optimal age for preferential recruitment in the MWM (Kee et al., 2007).
However, preferential recruitment was not observed since there was no
difference between the number of triple labeled cells in ethanol and control rats.
This was consistent with Geibig et al. (2012) who noted an increase in
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neurogenesis (in post-stroke mice) but an equal number of activated young
neurons (triple labeled neurons) compared to controls. These unexpected
results, however, may be the result of the very low number of triple labeled cells.
Although, low c-Fos expression was expected since only 1-2% of all dentate
granule cells express c-Fos in response to the present stimuli (Geibig et al.,
2012). These low cell counts are comparable (Geibig et al., 2012) or slightly
lower than previous studies (Kee et al., 2007). These results are counterintuitive
and difficult to explain.
Originally, the specificity of the triple label was viewed as a methodological
advantage since it allowed for highly precise labeling. Although in this instance
the specificity could be seen as a disadvantage since so few cells are labeled
which results in difficulty assessing the meaningfulness of such a small number
of cells. Increasing the number of triple labeled cells would be possible if the rats
were given BrdU injections over a longer period of time so that a larger
population could be captured. It is possible that a larger pool of cells to quantify
would reveal more triple labeled cells. However, it seems unlikely that this would
change the results since the ethanol animals already had a significant increase in
the number of neurons (BrdU/NeuN) and did not show a similar increase in the
number of triple labeled cells (and hundreds of cells were quantified for each
animal across all sections). Essentially, the percentage of cells that were triple
labeled did not change despite the large increase in the total number of BrdU+
cells in ethanol animals compared to controls. This lack of change was
unexpected since cells that are 6 weeks old have been shown to be preferentially
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incorporated (c-Fos+) following the MWM (Kee et al., 2007). Since there were
more newborn neurons in ethanol animals, we hypothesized that more of those
neurons would be available for recruitment in the MWM and that was not the
case. There were some potential differences that could shed light on the lack of a
difference in recruitment despite the increase in neurogenesis in ethanol animals.
The research done by Kee and colleagues in 2007 illustrated that there was a
preferential age when neurons are recruited for the MWM task, was done in
mice. Species differences in neurogenesis are known to exist between rats and
mice and could account for differences in the timing of when cells are considered
mature. Indeed, researchers have reported that in adult rats, young neurons
display mature neuronal markers and IEG expression 1-2 weeks before mice
(Snyder et al., 2009). Therefore, it is possible that looking at c-Fos expression 12 weeks earlier may have yielded different results. Although, the preferential
recruitment of newborn neurons in mice occurred when young neurons were 6-8
weeks old (Kee et al., 2007). Thus, investigating 4 week old neurons would likely
yield the same results seen in the 6 week old neurons.
We hypothesized that the increase in neurogenesis would also generate
an increased number of triple labeled cells that were activated following the
MWM; however, that was not the case. There was no difference between ethanol
and control rats in terms of the number of triple labeled cells, or the percentage
of BrdU+ cells that also expressed c-Fos/NeuN. However, MWM testing revealed
that ethanol animals located the platform more quickly than controls (typically
interpreted as an improvement in learning). These results are interesting since
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improved MWM performance typically correlates with increased neurogenesis
(Garthe et al., 2016; Geibig et al., 2012; van Praag et al., 2002), but the more
direct assay of cellular functional incorporation, the triple label, does not. Future
studies will focus on investigating a more in-depth time course of MWM testing to
determine when/if improvements in learning and memory normalize. Additionally,
future studies should investigate additional IEGs such as zif268 and Arc (Clark et
al., 2011; Stone et al., 2011b) in place of c-Fos in the triple-label because each
IEG has a slightly different expression profile, while still being indicative of
activation in response to a hippocampal-dependent task. For example, Zif268
expression is roughly four times higher than c-Fos and has been used to confirm
findings related to c-Fos expression (Geibig et al., 2012).
The goal of this project was to determine if neurons generated during
reactive neurogenesis were capable of activation in response to the MWM. While
there was an increase in the number of young neurons born during alcoholinduced reactive neurogenesis, there were no differences in the number of
activated newborn neurons between ethanol and control animals. However, there
were triple labeled cells in both ethanol and control animals. Therefore, we
concluded that the neurons generated during reactive neurogenesis were
capable of activation in response to MWM. However, this conclusion required
proof that c-Fos was activated as a direct result of the MWM. Indeed, previous
research has shown that rats not exposed to MWM expressed no detectable
levels of c-Fos with IHC (Jessberger and Kempermann, 2003). To confirm that cFos expression was undetectable in animals not exposed to the water maze,
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tissue sections from multiple animals (from a similar 4-day binge study) were
stained for c-Fos alongside a positive control (MWM rats) and we observed no cFos+ staining in animals that did not undergo the MWM. Therefore, although we
recognize the importance of this group, the lack of staining seen here allowed us
to conclude that a non-MWM group was not necessary for this study.
In conclusion, seven weeks post-binge alcohol exposure (six weeks after
the reactive increase in neurogenesis) animals exposed to alcohol performed
better on the MWM, an effect that likely is due to increases in neurogenesis,
which were confirmed with BrdU+/NeuN+ cell counts. The number of activated
neurons (c-Fos+/NeuN+) did not differ between ethanol and control animals.
Lastly, the number of triple labeled cells did not differ between ethanol and
control animals indicating that activation is similar between cells generated
during basal neurogenesis and cells generated during reactive neurogenesis.
Regardless of the treatment administered (and the fact that ethanol animals had
increased BrdU+/NeuN+ cell counts) a similar number of cells were activated in
ethanol and control rats. These data support the conclusion that neurons
generated during alcohol-induced reactive neurogenesis are capable of
becoming incorporated into hippocampal networks. Additionally, since there was
no difference between ethanol and controls in terms of the number of activated
neurons (c-Fos+/NeuN+), it indicates that activation may not be affected by binge
alcohol exposure at this time point (T52). We recognize that a triple-labeled cell
may not necessarily be functionally normal and this should be tested in future
studies. Although the number of activated neurons is very small, there is
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important research that indicates that the contribution of a small number of new
neurons could contribute substantially to the hippocampal network (Geibig et al.,
2012; Kempermann, 2008; Wiskott et al., 2006). In addition, activation in
response to MWM represents only one facet of functional integration (Geibig et
al., 2012). A complete analysis will require additional studies to investigate
connectivity and electrophysiological properties to ensure that neurons born
during reactive neurogenesis are properly functionally integrated.
This is the first study to investigate the function of alcohol-induced reactive
neurogenesis. The idea of triple labeling cells to determine if they are able to
functionally incorporate into the hippocampal circuits came from similar research
investigating reactive neurogenesis following an experimental model of a stroke
which revealed that reactive neurons were activated in response to MWM (Geibig
et al., 2012). Reactive neurogenesis occurring in response to alcohol-induced
neurodegeneration is potentially similar to other models of neurodegenerative
disease including stroke and TBI (Geil et al., 2014). Any neurodegenerative
disease that affects the hippocampus can result in deficits in hippocampaldependent learning and memory. Since ethanol decreases neurogenesis, it has
been postulated that this likely contributes to its neurodegenerative effects
(Armstrong and Barker, 2001; Nixon, 2006). Thankfully, research has shown that
some hippocampal functions can normalize with time and here we show that it is
possible that neurons generated during reactive neurogenesis could contribute to
this recovery.
Copyright © Chelsea Rhea Geil Nickell 2016
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CHAPTER 6: GENERAL CONCLUSIONS AND FUTURE DIRECTIONS
Excessive alcohol consumption can result in the development of an AUD,
commonly referred to as alcoholism. In the United States an estimated 30% of
the population will meet the criteria for an AUD at some point during their lifetime
(Hasin DS et al., 2007). Chronic alcoholics display cognitive deficits including
impairments in executive functioning, learning, and memory (Sullivan et al.,
2000). Indeed, human alcoholics and animal models of alcoholism show
hippocampal degeneration (Bengochea and Gonzalo, 1990; Taffe et al., 2010;
Walker et al., 1980; Zahr et al., 2010). Rodent models have been able to show
the relationship between excessive alcohol ingestion, cell death, and
corticolimbic neurodegeneration (Collins et al., 1996; Crews et al., 2006a; Walker
et al., 1980). Research has also shown that adult neurogenesis is essential for
maintaining hippocampal integrity (Gould et al., 1999; Imayoshi et al., 2008;
Shors et al., 2002). Additionally, rodent models have revealed a temporallyspecific increase in adult neurogenesis seen during abstinence from binge
alcohol exposure (Nixon and Crews, 2004). Reactive neurogenesis can be
observed following multiple forms of brain injury including TBI where research
has indicated a potential role for newborn neurons in hippocampal recovery
(Blaiss et al., 2011). Investigators utilized transgenic mice to show that neurons
generated during TBI-induced reactive neurogenesis were able to stably
incorporate into the hippocampus (Blaiss et al., 2011). Similarly, previous
research has shown that stroke-induced reactive neurogenesis also yielded
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newborn neurons capable of integration into hippocampal circuits (Geibig et al.,
2012).
The studies described in this dissertation aim to define the contribution of
reactive neurogenesis in hippocampal recovery following a binge model of an
AUD in rats. To address this novel aim the first experiments focused on
elucidating a methodological approach capable of successfully inhibiting alcoholinduced reactive neurogenesis. The next step was to examine how inhibiting
reactive neurogenesis affected learning and memory in a hippocampaldependent task (MWM). In order to normalize (inhibit or decrease) the alcoholinduced reactive increase in proliferation seen at T7, rats were exposed to four
days of binge alcohol followed by two additional doses of alcohol which were
given on T6/T7. Although high doses of alcohol had been previously successful
in decreasing basal levels of hippocampal proliferation (Nixon and Crews, 2002),
surprisingly, the additional doses of alcohol did not prevent the reactive increase
in proliferation. The fact that high doses of alcohol inhibit basal proliferation, but
not reactive proliferation, indicate that reactive proliferation is robust, possibly
due to its potential role in hippocampal recovery following an AUD. These results
prompted a more thorough investigation into the time frame surrounding alcoholinduced reactive proliferation (and subsequent reactive neurogenesis).
A timeline study investigated proliferation levels between four and seven
days post-binge. Results revealed that reactive proliferation begins on T5 and
lasts through T7. Discovering that proliferation was increased as early as T5 was
important for elucidating a method to normalize alcohol-induced reactive
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proliferation/neurogenesis. Without this timeline it would not have been clear that
reactive proliferation needed to be inhibited across multiple days.
Because our previous attempt to use alcohol to decrease reactive
proliferation was unsuccessful, we incorporated the use of TMZ to inhibit
neurogenesis. TMZ has been used for studies of basal neurogenesis and is
considered to be a well-tolerated drug among existing anti-proliferative agents
(Niibori et al., 2012; Nokia et al., 2012). Although new information regarding the
timeline of reactive proliferation may have provided the information needed to
properly time alcohol administration to decrease proliferation (ethanol could have
been given from T4-T6), we hypothesized that using a drug known to target
rapidly proliferating cells would allow for the greatest chance of success in
inhibiting rapidly proliferating NPCs. Therefore, TMZ was administered to overlap
with the reactive increase in proliferation seen on T5-T7. Importantly, TMZ
administration began before T5 to ensure that cells that were in the process of
replicating were inhibited. Essentially, cells may already be in the process of
proliferating by/on T4 and those T4 cells generate the increase seen on T5; for
this reason TMZ was administered prior to T5. Results revealed that TMZ
normalized the reactive increase in proliferation seen on T7, and the respective
increase in neurogenesis seen on T14. These experiments indicated that TMZ
was able to decrease alcohol-induced reactive proliferation and neurogenesis to
levels seen in controls without simply delaying reactive proliferation. As a result,
these experiments supported the use of TMZ as an effective method of inhibiting
alcohol-induced reactive neurogenesis and therefore these methods can be used
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in future experiments to study the function of inhibiting alcohol-induced reactive
neurogenesis.
One main objective of this dissertation was to determine the role of
alcohol-induced reactive neurogenesis in hippocampal recovery following a binge
model of an AUD. With TMZ successfully inhibiting reactive neurogenesis, an
important question could be asked: if reactive neurogenesis is inhibited, does it
prevent recovery of hippocampal function (assessed with MWM). Previously, our
lab has shown deficits in the MWM 7-10 days post-binge (Supplemental Figure
1). In the present studies rats were tested in the MWM when neurons produced
during reactive neurogenesis were four weeks old (T38). Interestingly, TMZ did
not appear to affect MWM behavior at this time point as there were no
differences between the different drug exposure groups (i.e. the ethanol-TMZ
rats preformed just as well as the control-saline group). These data indicated that
inhibiting reactive neurogenesis did not affect functional hippocampal recovery
measured by the MWM. While these results were unexpected (the original
hypothesis predicted that inhibiting reactive neurogenesis would prevent MWM
normalization), they are not totally unexpected. Previous research has shown
hippocampal recovery following alcoholism in humans (Bartels et al., 2007) and
animal models of AUDs (Lukoyanov et al., 2000) and as such, the present
findings support the conclusion that regeneration is possible. However, to be
thorough, future experiments should increase the complexity of the MWM test by
incorporating a reversal learning component which could result in a greater
challenge to the injured hippocampus, thereby revealing more subtle deficits not
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seen with standard MWM testing procedures (Garthe et al., 2009). Regardless of
the final conclusion of this line of research (i.e. whether reactive neurogenesis is
beneficial or inconsequential), it will provide a valuable addition to the field of
regeneration and hippocampal recovery following AUD.
The next part of this study investigated the functional incorporation of
neurons born during alcohol-induced reactive neurogenesis. Importantly, this
study did not use TMZ because the goal here was to investigate if reactive
neurons were capable of activation. Neurons born during alcohol-induced
reactive neurogenesis were allowed time to mature and incorporate into the
hippocampal circuitry. Here, results revealed that cells born during alcoholinduced reactive neurogenesis were capable of activation following the MWM
(although they may be less prone to activate). This finding is supported by
previous studies in other models of neurodegeneration, including stroke and TBI,
which have observed neuronal activation in response to reactive neurogenesis
(Blaiss et al., 2011; Geibig et al., 2012).
Here the MWM was used as a means to activate neurons generated
during reactive neurogenesis seven weeks post-binge alcohol exposure (Geibig
et al., 2012; Snyder et al., 2012). However, when all of the available post-binge
MWM data was considered it showed a time course with a deficit in MWM ~one
week post-binge that normalized by five weeks post-binge and then resulted in
an improvement in MWM in ethanol rats at seven weeks post-binge (compared to
controls). Importantly, the MWM timeline (one, five, and seven weeks post-binge)
in rats appears consistent with previous research that demonstrates an
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improvement in cortical grey matter volumes within four weeks of alcohol
abstinence in humans (O’Neill et al., 2001; Pfefferbaum et al., 1995).
Additionally, increased neurogenesis observed four to eight weeks post-insult in
animals correlated with improved performance on hippocampal-dependent tests
(Garthe and Kempermann, 2013; Kempermann and Gage, 2002b; van Praag et
al., 1999). Previous research has also shown that it can take four to eight weeks
for young neurons to mature and integrate into hippocampal networks (Deng et
al., 2010; Kee et al., 2007). Therefore, four week old neurons may not be fully
integrated by T38 and therefore may require at least six weeks to incorporate
(T52), particularly for the MWM (Kee et al., 2007). This timeline of maturation
could also explain why there was no change when neurons were four weeks old
(T38) but showed improvements seven-weeks post-binge (T52) in ethanol rats
with increased neurogenesis levels. To confirm the results that indicate that
alcohol rats outperform controls, the T52 MWM time point should be repeated
and include a reversal learning test and another hippocampal-dependent
behavioral test, such as contextual fear conditioning (Daumas et al., 2005;
Phillips and LeDoux, 1992). The combination of the experiments listed above
would allow for an in-depth investigation into the functional contribution of
reactive neurogenesis.
The function of newborn neurons is still being debated but most adult
neurogenesis studies agree that the constant generation of new neurons is
important for hippocampal function (including pattern separation). Young granule
neurons display different electrophysiological properties than fully mature granule

141

neurons which result in young neurons being highly active in the weeks following
functional incorporation (Nakashiba et al., 2012). Previous research has used
several methods to inhibit neurogenesis in an attempt to study how new neurons
contribute to hippocampal function with the newest methods involving the use of
transgenic rats to fully inhibit adult neurogenesis (Snyder et al., 2016).
Here we use TMZ to inhibit reactive neurogenesis following alcohol
exposure. Previous studies propose a role for adult neurogenesis as a potential
mechanism contributing to functional and structural repair of the hippocampus
following binge alcohol exposure (Nixon, 2006). This mechanism is supported by
a robust increase in neurogenesis (i.e. reactive neurogenesis) that occurs after
the cessation of binge alcohol consumption in rats. Furthermore, the correlation
between alcohol-induced increases in neurogenesis and improvements in
hippocampal-specific behavior are striking. Additionally, the young neurons
generated during reactive neurogenesis are activated when induced with a
hippocampus-specific task, which supports that they are functional. If neurons
are indeed functionally incorporated then they represent a potential mechanism
by which the brain can help repair itself. Additionally, it implies that neurogenesis
represents a target for therapeutic development in the treatment of AUDs.
Advances towards understanding reactive neurogenesis could contribute to the
development of interventions capable of improving abstinence success rates or
speeding up the process of neural recovery. There is high demand for
therapeutic-based treatment options for AUDs since currently, only three
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medications are FDA approved: aversive compounds, opioid receptor
antagonists, and glutamate-based interventions.
It should be noted that not all studies show a role for adult neurogenesis
or reactive neurogenesis in hippocampal recovery. One study ablated adult
neurogenesis only to reveal that the brain was able to compensate and recover
normal LTP function despite neurogenesis being completely inhibited (Singer et
al., 2011). Another study showed that although chronic alcohol exposure resulted
in significant neuronal loss in multiple hippocampal regions, the rodent brain was
able to reorganize (potentially at the synaptic level), such that functional deficits
were not observed (Lukoyanov et al., 2000). As such, we must consider the
possibility that the brain is capable of compensating for a lack of adult
neurogenesis, which may complicate an assessment of the function of alcoholinduced reactive neurogenesis. However, the present research indicates that
hippocampal deficits are recoverable and neurons born during reactive
neurogenesis are not only functionally incorporated, but potentially lead to
improvements in hippocampal function. Therefore, further investigation should
remain a priority, especially with the long-term prospect of revealing novel targets
to treat neurodegenerative disorders including AUDs.

Copyright © Chelsea Rhea Geil Nickell 2016
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APPENDIX
SUPPLEMENTAL FIGURE 1

Supplemental Figure - EtOH (ethanol) rats swim longer distances before locating
the hidden platform which is indicative of a learning deficit. Binge alcohol disrupts
spatial learning in the MWM 1 week (7-10 days) after a 4-day binge alcohol
treatment (n=7). **p<0.05. Figure and data reproduced with permission from Dr.
Nixon and Dr. Pauly.
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ABBREVIATIONS
AAALAC, Association for assessment and accreditation of laboratory animal care
ANOVA, analysis of variance
AUD, alcohol use disorder
BEC, blood ethanol concentration
BrdU, bromodeoxyuridine
CA, cornu amonis
CREB, cAMP response element binding protein
CNS, central nervous system
DAB, 3,3’-diaminobenzidine tetrahydrochloride
DCX, doublecortin
DG, dentate gyrus
dH2O, distilled water
DNA, deoxyribonucleic acid
DSM, diagnostic and statistical manual of mental disorders
FASD, fetal alcohol spectrum disorders
GABA, gamma-amino-butyric acid
GCL, granule cell layer
GFAP, glial fibrillary acidic protein
Iba1, ionized calcium-binding adapter molecule 1
IEG, immediate early gene
IgG, immunoglobulin G
IHC, immunohistochemistry
i.p., intraperitoneal
LTP, long-term potentiation
MRI, magnetic resonance imaging
MWM, Morris water maze
nAChR, nicotinic acetylcholine receptor
NeuN, neuronal nuclei
NeuroD, neurogenic differentiation factor 1
NIAAA, National Institute on Alcohol Abuse and Alcoholism
NIH, National Institute of Health
NMDA, N-methyl-D-aspartate
NPC, neural progenitor cell
PBS, phosphate buffered saline
PBST, phosphate buffered saline + Triton-x
PFA, paraformaldehyde
PND, postnatal day
SGZ, subgranular zone
S-phase, synthesis phase of cell cycle
SSC, standard sodium citrate
TBI, traumatic brain injury
TBS, tris buffered saline
TMZ, temozolomide
WD, withdrawal
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